{
  "NCT06331130": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.95,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.95,
    "source": "manual_intelligence_report",
    "tagged_at": "2025-01-13T12:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "intelligence_report": ".cursor/ayesha/zo_intelligence_reports/INTELLIGENCE_NCT06331130_TOP_TIER.md",
      "extraction_method": "manual_review",
      "primary_moa": "HER2-targeted therapy (Trastuzumab deruxtecan with Zanidatamab)"
    }
  },
  "NCT04284969": {
    "moa_vector": {
      "ddr": 0.95,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.95,
    "source": "manual_intelligence_report",
    "tagged_at": "2025-01-13T12:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "intelligence_report": ".cursor/ayesha/zo_intelligence_reports/INTELLIGENCE_NCT04284969_TOP_TIER.md",
      "extraction_method": "manual_review",
      "primary_moa": "DNA Damage Repair (PARP + ATR inhibitors)"
    }
  },
  "NCT04001023": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.9,
    "source": "manual_intelligence_report",
    "tagged_at": "2025-01-13T12:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "intelligence_report": ".cursor/ayesha/zo_intelligence_reports/INTELLIGENCE_NCT04001023_TOP_TIER.md",
      "extraction_method": "manual_review",
      "primary_moa": "DNA Damage Repair (PARP inhibitor Olaparib)"
    }
  },
  "NCT01000259": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.9,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.9,
    "source": "manual_intelligence_report",
    "tagged_at": "2025-01-13T12:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "intelligence_report": ".cursor/ayesha/zo_intelligence_reports/INTELLIGENCE_NCT01000259_TOP_TIER.md",
      "extraction_method": "manual_review",
      "primary_moa": "VEGF Angiogenesis Inhibition (Bevacizumab)"
    }
  },
  "NCT02655016": {
    "moa_vector": {
      "ddr": 0.95,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.95,
    "source": "manual_intelligence_report",
    "tagged_at": "2025-01-13T12:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "intelligence_report": ".cursor/ayesha/zo_intelligence_reports/INTELLIGENCE_NCT02655016_TOP_TIER.md",
      "extraction_method": "manual_review",
      "primary_moa": "DNA Damage Repair (PARP + Ceralasertib ATR inhibitor)"
    }
  },
  "NCT04164979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.9,
      "her2": 0.0,
      "io": 0.9,
      "efflux": 0.0
    },
    "confidence": 0.75,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "vegf:cabozantinib",
        "io:pembrolizumab"
      ],
      "primary_moa": "VEGF pathway (cabozantinib)"
    }
  },
  "NCT04123379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.9,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "io:nivolumab"
      ],
      "primary_moa": "IO pathway (nivolumab)"
    }
  },
  "NCT02244879": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atr"
      ],
      "primary_moa": "DDR pathway (atr)"
    }
  },
  "NCT06631079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.9,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "io:pd-1"
      ],
      "primary_moa": "IO pathway (pd-1)"
    }
  },
  "NCT06332079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.9,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "vegf:bevacizumab"
      ],
      "primary_moa": "VEGF pathway (bevacizumab)"
    }
  },
  "NCT04986579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.9,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "her2:trastuzumab"
      ],
      "primary_moa": "HER2 pathway (trastuzumab)"
    }
  },
  "NCT03735979": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atr"
      ],
      "primary_moa": "DDR pathway (atr)"
    }
  },
  "NCT00072579": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT03878979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.9,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "io:nivolumab"
      ],
      "primary_moa": "IO pathway (nivolumab)"
    }
  },
  "NCT05042479": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atr"
      ],
      "primary_moa": "DDR pathway (atr)"
    }
  },
  "NCT02680379": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT00652379": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT04850079": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT03470779": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT06395779": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atr"
      ],
      "primary_moa": "DDR pathway (atr)"
    }
  },
  "NCT02422979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.9,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "io:immunotherapy"
      ],
      "primary_moa": "IO pathway (immunotherapy)"
    }
  },
  "NCT00339079": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT04534179": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT02575079": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.9,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.75,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atr",
        "mapk:raf"
      ],
      "primary_moa": "DDR pathway (atr)"
    }
  },
  "NCT05338879": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT01226979": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT04470479": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT01609179": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT05799079": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT06108479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.9,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "io:pembrolizumab"
      ],
      "primary_moa": "IO pathway (pembrolizumab)"
    }
  },
  "NCT06101979": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atr"
      ],
      "primary_moa": "DDR pathway (atr)"
    }
  },
  "NCT01321879": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT06963879": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT02359279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.9,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "mapk:ras"
      ],
      "primary_moa": "MAPK pathway (ras)"
    }
  },
  "NCT01091779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.9,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "mapk:ras"
      ],
      "primary_moa": "MAPK pathway (ras)"
    }
  },
  "NCT00006379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.9,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "mapk:raf"
      ],
      "primary_moa": "MAPK pathway (raf)"
    }
  },
  "NCT06638879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.9,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "mapk:raf"
      ],
      "primary_moa": "MAPK pathway (raf)"
    }
  },
  "NCT01979679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.9,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "mapk:ras"
      ],
      "primary_moa": "MAPK pathway (ras)"
    }
  },
  "NCT01961479": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT05190679": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atr"
      ],
      "primary_moa": "DDR pathway (atr)"
    }
  },
  "NCT02498379": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atr"
      ],
      "primary_moa": "DDR pathway (atr)"
    }
  },
  "NCT02364479": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT00574379": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT04521179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.9,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "her2:her2"
      ],
      "primary_moa": "HER2 pathway (her2)"
    }
  },
  "NCT00501579": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT05201079": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT03479879": {
    "moa_vector": {
      "ddr": 0.9,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "manual_keyword_matching",
    "tagged_at": "2025-01-13T18:00:00Z",
    "reviewed_by": "Zo",
    "provenance": {
      "method": "keyword_matching",
      "keywords_matched": [
        "ddr:atm"
      ],
      "primary_moa": "DDR pathway (atm)"
    }
  },
  "NCT05531279": {
    "moa_vector": {
      "ddr": 0,
      "mapk": 0,
      "pi3k": 0,
      "vegf": 0,
      "her2": 0,
      "io": 0,
      "efflux": 0
    },
    "confidence": 0.8,
    "primary_moa": "Growth factor",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:30:08.636835",
      "source_checksum": "4e314fccf8c1bdbf23f01403a9583377",
      "source": "llm_batch_tagging"
    }
  },
  "NCT06030479": {
    "moa_vector": {
      "ddr": 0,
      "mapk": 0,
      "pi3k": 0,
      "vegf": 0,
      "her2": 0,
      "io": 0,
      "efflux": 0
    },
    "confidence": 0.7,
    "primary_moa": "Vasoconstriction",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:30:08.636872",
      "source_checksum": "b598b2c765680c10aae978f0a28b6ccf",
      "source": "llm_batch_tagging"
    }
  },
  "NCT06326879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:22.201125Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:22.201134Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5d4c20c487b179d0d31eacd7b2ea5c30",
      "primary_moa": "No intervention; observational study"
    }
  },
  "NCT06233279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:26.349165Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:26.349172Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "aa985e34b6abd0cef87a71b7634d548c",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT06724679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:28.884560Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:28.884567Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cbf0faf33522ea4a3aeb89f226390f90",
      "primary_moa": "No clear pharmacological mechanism"
    }
  },
  "NCT07017179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:30.695145Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:30.695155Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "857a0adc7d2f22b9fadd656b0f536a2e",
      "primary_moa": "No clear mechanism identified"
    }
  },
  "NCT05800379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:33.622447Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:33.622455Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "eedbb36abe893d15ebeef347be3b2858",
      "primary_moa": "No clear mechanism identified"
    }
  },
  "NCT05943379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.7,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:35.848721Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:35.848725Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "29a98baf0860f85644367ba2984268bf",
      "primary_moa": "HER2 pathway inhibition"
    }
  },
  "NCT06377579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:37.293154Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:37.293162Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "22e6bec11ce238814935460d337f72f9",
      "primary_moa": ""
    }
  },
  "NCT04872179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:39.940206Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:39.940211Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b70bddcb5fee891abbbbfcfd1a433813",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT06962579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:43.036142Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:43.036146Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8cd11447056892dd8a968436c4eb48eb",
      "primary_moa": "No clear mechanism of action related to exercise intervention"
    }
  },
  "NCT06584279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "openai_batch_tagging",
    "tagged_at": "2025-12-24T09:43:44.139709Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gpt-4o",
      "version": "v1",
      "parsed_at": "2025-12-24T09:43:44.139722Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8ce784fb6e963dce6a90cecbd97e7c52",
      "primary_moa": "No clear mechanism of action related to the specified pathways"
    }
  },
  "NCT06373679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 1.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:00:40.541073Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:00:40.541110Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b908785acc370b8ab7eb1f0dd2d0e106",
      "primary_moa": "None of the specified mechanisms are targeted. The trial focuses on smoking cessation via nicotine replacement or nicotinic acetylcholine receptor modulation."
    }
  },
  "NCT06536179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.9,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:00:51.744144Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:00:51.744170Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b11f08accfd5d4e85710e75656bb21c7",
      "primary_moa": "Immunomodulation targeting inflammation (HMGB1) and cell trafficking/tumor microenvironment modulation (CXCR4)."
    }
  },
  "NCT05700279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 1.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:00:57.294115Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:00:57.294179Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d54b21a7cfe2fa8629fed712b4d00aa7",
      "primary_moa": "The interventions are procedural (Stellate Ganglion Block) and psychological (Cognitive Processing Therapy), not targeting specific molecular pathways listed in the MoA vector."
    }
  },
  "NCT04158479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:01:05.655821Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:01:05.655852Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "854298ad1ace4864b37ce4eb013299be",
      "primary_moa": "Mechanical cardiac and respiratory support"
    }
  },
  "NCT03821779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:01:10.503258Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:01:10.503266Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "799c6ce6c0a6be44fd983a71467c0b5b",
      "primary_moa": "The trial focuses on biomarker identification and behavioral assessment for anxiety, not on pharmacological intervention targeting the provided molecular mechanisms of action."
    }
  },
  "NCT06748079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:01:14.468009Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:01:14.468031Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "250457204d927f8e56572671ae21ed3f",
      "primary_moa": "Undetermined from provided information; the description focuses on safety, tolerability, and pharmacokinetics without specifying a molecular target or pathway relevant to the given MoA categories."
    }
  },
  "NCT03622879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:01:43.393319Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:01:43.393351Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "03eef570d31d88d4d5e81ca71f90929b",
      "primary_moa": "The trial involves physical rehabilitation and neurological stimulation techniques, which do not align with the provided molecular mechanism of action categories."
    }
  },
  "NCT03672279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 1.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:01:48.233527Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:01:48.233567Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "fd532ed0df8e72740548fc08846e00ef",
      "primary_moa": "Diagnostic/assessment tool for cognitive function, not a therapeutic agent targeting specified biological pathways."
    }
  },
  "NCT06958679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:03:21.565323Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:03:21.565366Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2585e87181416f2fe4142568ec27d583",
      "primary_moa": "No mechanism of action information provided for SYS6005 in the trial description."
    }
  },
  "NCT03368079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:03:39.600320Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:03:39.600337Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "33dc8ba7986a987c77e4500be044d92f",
      "primary_moa": "Mechanical intervention (negative pressure suction) to reduce aspiration."
    }
  },
  "NCT06291779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 1.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:03:57.608603Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:03:57.608634Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b72b70db2ef9e3b0e4d4d1a143436eec",
      "primary_moa": "This is a diagnostic study focused on biomarker analysis (purine metabolites) for pancreatic cancer detection, not a therapeutic intervention targeting any of the provided MoA categories."
    }
  },
  "NCT02777879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:04:19.502605Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:04:19.502617Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c7991bdb9e10e583ec9b6439d5c72313",
      "primary_moa": "Not applicable; this is an observational study assessing disease mechanisms rather than an interventional trial with a specific therapeutic MoA."
    }
  },
  "NCT05006079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:04:39.177541Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:04:39.177593Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "14554bf7be120ea709bbaa62c73881ba",
      "primary_moa": "The trial investigates the effects of opioid receptor agonists (Morphine) and GABA-A receptor potentiators (Alprazolam) in polysubstance abuse, mechanisms which are not represented in the provided MoA vector categories."
    }
  },
  "NCT07005479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 1.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:04:58.729758Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:04:58.729773Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6e8a7f46d2929654db3dbe0c60a8168d",
      "primary_moa": "This is an observational study with no specified therapeutic intervention, therefore no drug-related mechanism of action is applicable."
    }
  },
  "NCT06558279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.95,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:05:17.740119Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:05:17.740138Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "66ea77e03898612d6a1d1225431c7819",
      "primary_moa": "FcRn antagonist, reducing circulating IgG autoantibodies to modulate the immune response."
    }
  },
  "NCT06699979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:05:36.733910Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:05:36.733934Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d832e635ce23447e6b2529b698421f25",
      "primary_moa": "No specific therapeutic mechanism of action is being investigated as this is an observational, multi-omics study aimed at characterizing lung cancer and identifying potential targets, rather than evaluating an intervention with a defined MoA."
    }
  },
  "NCT06680479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 1.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:05:55.946893Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:05:55.946935Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8c9110ab424bbea4aa2d05758da159db",
      "primary_moa": "Vaccine-mediated induction of antigen-specific B-cell neutralizing immune responses."
    }
  },
  "NCT06883279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:06:15.564871Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:06:15.564906Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dbd221940ca43d9998ff8cbb066464e9",
      "primary_moa": "The mechanism of action for local anesthetics (nerve blockade) is not represented in the predefined categories."
    }
  },
  "NCT05147779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.85,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:06:41.398346Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:06:41.398384Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "89450d57fe6518839767f5120b22a415",
      "primary_moa": "Mesenchymal stem cells exert immunomodulatory and anti-inflammatory effects, which is a form of immunotherapy."
    }
  },
  "NCT05263479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.9,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:08:26.604797Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:08:26.604831Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8ab479d8b99bda7f92dc9b751aa4fbc8",
      "primary_moa": "Targeting of the immune checkpoint B7-H4 with an antibody-drug conjugate."
    }
  },
  "NCT06060379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:09:06.406554Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:09:06.406572Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "373429589f8b0ba65c109792aa778b41",
      "primary_moa": "The intervention is an educational training course using games, not a pharmacological or biological intervention targeting molecular pathways. Therefore, none of the predefined MoA categories apply."
    }
  },
  "NCT06684379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.9,
    "source": "gemini_batch_tagging",
    "tagged_at": "2026-01-08T20:26:21.940821Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v1",
      "parsed_at": "2026-01-08T20:26:21.940916Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "067661bf0f0c28a27e6a8355f1b98f71",
      "primary_moa": "Immunomodulation by mesenchymal stromal cell-derived factors to prevent cytokine storm"
    }
  },
  "NCT06777979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 1.0,
    "source": "gemini_batch_v2",
    "tagged_at": "2026-01-08T22:23:58.983260Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v2",
      "batch_size": 5,
      "primary_moa": "Immunotherapy (CD19-CD22 CAR T cell therapy)",
      "source_checksum": "2ff3ed1c7898"
    }
  },
  "NCT05675579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.95,
    "source": "gemini_batch_v2",
    "tagged_at": "2026-01-08T22:23:55.213492Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "gemini-2.5-flash",
      "version": "v2",
      "batch_size": 5,
      "primary_moa": "Immunotherapy (PD-1 inhibition by Pembrolizumab)",
      "source_checksum": "379b47734af8"
    }
  },
  "NCT05761379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.6,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:21:10.859249Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "version": "v1",
      "parsed_at": "2026-01-08T23:21:10.859259Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bc3b05b1448c2dcfc61f8c7205a9a620",
      "primary_moa": "Photobiomodulation Therapy (PBM) may primarily affect myopia progression through its influence on the visual system and neural pathways, potentially modulating cellular processes and gene expression."
    }
  },
  "NCT06189079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:42:00.696109Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:42:00.696118Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c487543ee946d145244fa9488b132917",
      "primary_moa": "Arterial embolization likely reduces pain and localizes disease by cutting off blood supply to bone metastases, but it does not directly target DNA damage repair, MAPK, PI3K/AKT, angiogenesis, HER2, or drug efflux pathways."
    }
  },
  "NCT04032379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:17.034952Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:17.034977Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "184a2e52c8eef8243961b637ab22abf5",
      "primary_moa": "The primary mechanism of action is likely related to the management of symptoms and complications associated with Idiopathic Intracranial Hypertension (IIH), focusing on reducing intracranial pressure and managing associated symptoms."
    }
  },
  "NCT06774079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:20.966611Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:20.966644Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "429dede8a8f5c2ce9f6da3274a056952",
      "primary_moa": "The primary mechanism of action is likely related to the GLP-1 receptor agonism and its effects on glucose metabolism and gut physiology, which may indirectly impact inflammation in Crohn's disease patients."
    }
  },
  "NCT06010979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:24.908128Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:24.908135Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7e61b9dd08818e14b676184db481c904",
      "primary_moa": "This trial focuses on the use of digital technologies in knee arthroplasty, suggesting a focus on enhancing surgical precision and potentially reducing complications."
    }
  },
  "NCT06186479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:28.645923Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:28.645934Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3b4138bd74f18c6c0fb2bcce41d84a4b",
      "primary_moa": "Neuroprotective effect of Aconite pain oil against chemotherapy-induced polyneuropathy"
    }
  },
  "NCT05731479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:32.440193Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:32.440200Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ac9f6a82aa6d9a2daa64f1d0ca7d1c11",
      "primary_moa": "The primary mechanism of action appears to be the combination of physical therapy and thermal therapy, which may enhance muscle repair and recovery, potentially through increased blood flow and reduced inflammation."
    }
  },
  "NCT05154279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:36.205110Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:36.205123Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cec7495395ca7a58f115b996fafa1f96",
      "primary_moa": "Terlipressin is a vasoconstrictor that may reduce blood loss during surgery by constricting blood vessels, potentially affecting hemoglobin levels."
    }
  },
  "NCT06342479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:40.066230Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:40.066250Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "60d201be7c749f867d15d38f7857b82f",
      "primary_moa": "Wound healing and recovery"
    }
  },
  "NCT05739279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:44.214765Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:44.214784Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c9892eec5767ed9f89f631cff029baac",
      "primary_moa": "The trial suggests a focus on muscle strength and exercise capacity, which may indicate a primary mechanism related to muscle function and metabolism."
    }
  },
  "NCT05977179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:48.308318Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:48.308324Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6144dbb3491e098bf162f87ec6cd1347",
      "primary_moa": "The primary mechanism of action is likely related to the anti-inflammatory properties of the dietary intervention, which may target multiple pathways involved in the pathophysiology of Post-Acute COVID-19 Syndrome."
    }
  },
  "NCT06330779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.3,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:52.114375Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:52.114382Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0fc8afa83adc8f76d71efa3f9da4cbec",
      "primary_moa": "Trauma-adapted yoga may primarily influence mental health and quality of life through its impact on stress response and emotional regulation, potentially affecting conditions like ADHD and PTSD."
    }
  },
  "NCT06511479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:55.890798Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:55.890866Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7f2cc9167e3dd261bafcc7262ca00bf7",
      "primary_moa": "Mindfulness training may help regulate stress and emotional responses, potentially impacting hypertension through behavioral and psychological mechanisms."
    }
  },
  "NCT06242379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:43:59.735693Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:43:59.735699Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "229ad198e862e320b929dafbe7d9b4de",
      "primary_moa": "Stem cell small extracellular vesicles (sEVs) may modulate the immune response and promote angiogenesis in retinitis pigmentosa."
    }
  },
  "NCT05078879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:03.566114Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:03.566120Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b89edd52666e878fc7e40b097959a629",
      "primary_moa": "Empagliflozin may modulate immune response and inflammation, potentially affecting neutrophil production and function in SCN patients."
    }
  },
  "NCT06597279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:07.772268Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:07.772304Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "39e89a78fe8409defc9626fd67b8e33a",
      "primary_moa": "The trial focuses on a web-based decision support tool for individuals with advanced chronic kidney disease, aiming to improve decisional outcomes. This suggests a focus on patient education and decision-making support rather than direct biological mechanisms."
    }
  },
  "NCT04274179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:11.658381Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:11.658404Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "398a0ad9ca46cdd62ab5b48e332f0944",
      "primary_moa": "The ketogenic diet is a dietary therapy that alters the body's metabolic state, potentially reducing seizure activity by altering brain energy metabolism and neurotransmitter levels."
    }
  },
  "NCT05891379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:15.546607Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:15.546624Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d6f4021f8f390f5c24450ba26fb5beb5",
      "primary_moa": "Immunomodulatory therapy targeting B-cells"
    }
  },
  "NCT06280079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:19.488368Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:19.488381Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d55d7e33af72bd3a92b83971f8026094",
      "primary_moa": "The primary mechanism of action is likely related to the nutritional intervention's impact on energy metabolism and potentially neuroprotection in ALS patients."
    }
  },
  "NCT05341479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:23.740253Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:23.740264Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "59750bda38e6613915593433ca4f4901",
      "primary_moa": "This trial focuses on the treatment of oropharyngeal carcinoma (OPC) with various interventions, including surgery, radiation therapy (RT), chemotherapy (CRT), and neoadjuvant treatment. The primary mechanism of action is likely related to the modulation of the immune system and the inhibition of tumor growth and spread."
    }
  },
  "NCT06595979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:27.731263Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:27.731269Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4f308d2e63fc19829f103f8cc510d5c2",
      "primary_moa": "Polymyxin B directly targets bacterial infections, particularly those caused by carbapenem-resistant Gram-negative bacteria (CRGNB)."
    }
  },
  "NCT05639179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:31.624246Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:31.624258Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6ccde7ca7171a8a8cb9598bd1e36250a",
      "primary_moa": "Immunotherapy (CAR-T cell therapy)"
    }
  },
  "NCT05839379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:35.517627Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:35.517668Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "94f4ab2989b85460a578ac8d79a39a3d",
      "primary_moa": "Genetic sequencing and molecular profiling of brain tumors to identify specific genetic alterations for personalized treatment"
    }
  },
  "NCT05381779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:39.409384Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:39.409392Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ff716992ef4c251025b40d91c103ef59",
      "primary_moa": "This trial focuses on improving exercise capacity and respiratory muscle strength in COVID-19 patients, suggesting a primary mechanism of action related to respiratory and physical activity enhancement."
    }
  },
  "NCT06759779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:43.336422Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:43.336428Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "afb47f518f2b00b6e11b0338c391ac56",
      "primary_moa": "This trial focuses on the effects of inspiratory and expiratory muscle training on respiratory muscle strength, pulmonary function, and performance in adolescent athletes. The primary mechanism of action is likely related to the physiological adaptations of the respiratory muscles rather than a direct molecular pathway."
    }
  },
  "NCT06117579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:47.117033Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:47.117051Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a41ff7106330d20de49435aaa5ffc18e",
      "primary_moa": "The primary mechanism of action is likely related to the reduction in upper airway caliber and the role of surrounding muscle hypotonia in obstructive sleep apnea syndrome."
    }
  },
  "NCT06737679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.5,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:51.135191Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:51.135199Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "892e6aa83651bf8af36d97bb6611ea89",
      "primary_moa": "The study's focus on enteroception in heart failure patients suggests a potential impact on the gut-brain axis, which may involve immune modulation and neuroinflammation."
    }
  },
  "NCT05949879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:55.052045Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:55.052077Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e794e63e234ed06f7b28a724ebf28e76",
      "primary_moa": "The primary mechanism of action is likely related to the anti-inflammatory and antioxidant properties of pecans, which are rich in bioactive compounds such as phenols, sterols, and flavonoids."
    }
  },
  "NCT03600779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:44:58.861561Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:44:58.861569Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d5cd610ed0ddfcd02ba48eeb23408e1d",
      "primary_moa": "In vivo biomarker development for myelin disruption and remyelination in multiple sclerosis"
    }
  },
  "NCT05656079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.6,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:02.758957Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:02.758972Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dc3fc501305fe2a6b39229ce79d0d932",
      "primary_moa": "HER2 pathway and Immunotherapy"
    }
  },
  "NCT06213779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:06.746679Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:06.746693Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3087596116e8a397ebe38ea71aab9d30",
      "primary_moa": "The study focuses on the burden and outcomes of acute respiratory failure and ARDS, which are primarily managed through respiratory support. While there is no direct mention of specific molecular targets or pathways, the primary mechanism of action is likely related to the management of respiratory support and the underlying pathophysiology of ARDS."
    }
  },
  "NCT06893679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:10.637423Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:10.637429Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5dc6bd1688b745f4ed2c4cfbc64d0d4a",
      "primary_moa": "Sensory modulation and behavior improvement in children with autism through Qigong sensory training"
    }
  },
  "NCT04621279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:14.843682Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:14.843688Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c04637f4de02615a15afc7e183c2e0e5",
      "primary_moa": "The primary mechanism of action appears to be related to the modulation of temperature-based therapies, specifically hypothermia, which is known to reduce brain injury and improve neurodevelopmental outcomes in infants with mild HIE."
    }
  },
  "NCT05735379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:18.728406Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:18.728412Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "84b287060338ad8d2907ced6a02d80fa",
      "primary_moa": "The primary mechanism of action is likely related to the reduction of the burden of potentially inappropriate medications, which can lead to improved physical function in older adults."
    }
  },
  "NCT06930079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.6,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:22.620640Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:22.620692Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cec5389c144f9e39b5d06b45a2dc37c2",
      "primary_moa": "The trial involves the use of autologous fat tissue, which suggests a focus on tissue regeneration and healing. This could potentially involve the MAPK pathway for tissue repair and regeneration."
    }
  },
  "NCT06572579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:26.513200Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:26.513217Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "565940464ca55ecf4031eede5605ddc5",
      "primary_moa": "Ultrasound-guided pharmacopuncture may modulate the immune response and reduce inflammation, potentially affecting pain management."
    }
  },
  "NCT05706779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 1.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:30.231754Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:30.231764Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f6e6fc180c67dd23401c05d92ee788f7",
      "primary_moa": "RAS/MAPK pathway inhibition with encorafenib and cetuximab"
    }
  },
  "NCT03407079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:34.297448Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:34.297462Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6ee5e8cc58a90fc92440e10309f7c0f7",
      "primary_moa": "Sucralose may affect drug absorption and metabolism, potentially through its impact on gut bacteria and fat cell metabolism."
    }
  },
  "NCT06537479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:38.280643Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:38.280661Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d4c25b77a56008b2cd2958b4ea720dd2",
      "primary_moa": "The trial focuses on the effects of breathing techniques and chest wall mobilization on pulmonary functions and quality of life in chronic smokers. This suggests a primary mechanism related to respiratory health and potentially inflammation or oxidative stress reduction."
    }
  },
  "NCT06429579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:42.590723Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:42.590743Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8b4243ee5296056e0433c5b51469b660",
      "primary_moa": "The trial focuses on the Potts-shunt procedure, which is a surgical intervention aimed at improving blood flow in patients with severe pulmonary artery hypertension (PAH). This suggests a focus on vascular remodeling and right ventricular support, which can be considered a form of angiogenesis and VEGF-dependent pathway modulation."
    }
  },
  "NCT06391879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:46.686915Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:46.686959Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "97e0d58d9ece43ce0167bd379c97c641",
      "primary_moa": "The primary mechanism of action is likely related to the genetic and molecular changes associated with VHL syndrome, particularly the mutation of the VHL tumor suppressor gene, which leads to the development of renal cell carcinoma."
    }
  },
  "NCT05960279": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:50.496865Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:50.496879Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "20b2b4db0640ba1aa1fb7c8a8b5ae49a",
      "primary_moa": "The MD100 device is designed to detect strokes, particularly those caused by bleeds. This suggests a focus on vascular health and blood-brain barrier integrity, which could be related to DDR and IO mechanisms."
    }
  },
  "NCT05546879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:54.567766Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:54.567775Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "74b46d37fa527b52e90219cebfa1a0ec",
      "primary_moa": "The trial focuses on the combination of NP137 with Atezolizumab-Bevacizumab to enhance tumor response and survival in unresectable HCC. This suggests a focus on angiogenesis inhibition and potentially immunotherapy."
    }
  },
  "NCT06543979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:45:58.460569Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:45:58.460577Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a437149b44865242902b730857e735ce",
      "primary_moa": "The primary mechanism of action appears to be related to the treatment of chronic constipation in children, focusing on sphincter dysfunction and pelvic floor dyssynergia."
    }
  },
  "NCT06007079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:02.351680Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:02.351723Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6fd75636652541393f2977429513ea43",
      "primary_moa": "The trial focuses on the deployment and interoperability of a CPM System in a home setting for Heart Failure patients, suggesting a focus on monitoring and data acquisition rather than direct therapeutic intervention."
    }
  },
  "NCT06651879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.6,
      "pi3k": 0.4,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:06.550674Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:06.550683Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d42e99b5582198b2f83089e8cb24d453",
      "primary_moa": "The trial focuses on ultrasound assessment of the airway in critically ill preeclamptic patients, suggesting a focus on improving intubation and ventilation techniques. This may involve mechanisms related to airway anatomy and physiology, potentially involving the MAPK pathway for airway smooth muscle relaxation and the PI3K/AKT pathway for airway inflammation and edema."
    }
  },
  "NCT04960579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:11.074603Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:11.074629Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a0040ffa983a35b8aae3cfb7fb3e4245",
      "primary_moa": "Immunotherapy (CAR-T cell therapy)"
    }
  },
  "NCT06672679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:15.150710Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:15.150725Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "495b53e3012cf8fcd5cb878c1757b749",
      "primary_moa": "The trial focuses on a family-based intervention for dating violence prevention, targeting Latine caregivers and adolescents. This suggests a primary mechanism of action related to behavioral and social interventions, potentially influencing family dynamics and communication."
    }
  },
  "NCT06858579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:19.247901Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:19.247908Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d1ef581263148c833ca84836ed438d3d",
      "primary_moa": "DNTH103 is an anti-inflammatory agent targeting the immune response in CIDP."
    }
  },
  "NCT05134779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:23.142938Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:23.142956Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "75ae9a33fac264082fe9e256f7cb664a",
      "primary_moa": "Immunotherapy and Targeted Therapy for Breast Cancer"
    }
  },
  "NCT06358079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:27.132151Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:27.132167Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e7aa5792c247c570848811f03234c5d4",
      "primary_moa": "Re-infusion of unwashed shed blood may have a primary mechanism related to the immune response and inflammation, potentially affecting cardiovascular complications."
    }
  },
  "NCT05264779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:31.060666Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:31.060673Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9c40c7e2826d039f6682f4083b0a5da6",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT06473779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:32.049132Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:32.049138Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d1639ea01129d4d75ee9f9d40a60f782",
      "primary_moa": "Tezepelumab is an IL-23 inhibitor, which targets the immune system and reduces inflammation in severe asthma."
    }
  },
  "NCT06478979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:36.249748Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:36.249766Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0729b45b7833e49e3d55ce0f3f983003",
      "primary_moa": "Neuclare, a medical device, is designed to improve gait in patients with Idiopathic Normal Pressure Hydrocephalus (iNPH). The trial focuses on gait improvement, suggesting a potential mechanism related to motor function and neurological recovery."
    }
  },
  "NCT04246879": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.4,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:40.230437Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:40.230454Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b5b3cc6f1214e7bc3bf718b880294162",
      "primary_moa": "The study focuses on distinguishing radiation damage from tumor recurrence, which suggests a role in DNA damage repair and potentially angiogenesis."
    }
  },
  "NCT04636879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:44.176340Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:44.176353Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d5a06e9e5717b74b2b2d6581d653f1e3",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT03472079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:48.027574Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:48.027591Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b347be08244046b3dcfe60ad88922e3f",
      "primary_moa": "The primary mechanism of action is likely related to the regulation of the immune response and the reduction of inflammation, as septic shock is an immune-mediated condition."
    }
  },
  "NCT06499779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:51.647059Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:51.647070Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6757bb7b8f1ac302573e57e5498d87a7",
      "primary_moa": "Neurodevelopmental disorders and congenital malformations"
    }
  },
  "NCT04640779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.3,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:55.499843Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:55.499872Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5906f2b060cca2f7a47ed3bfaa126845",
      "primary_moa": "Choline salicylate is an anti-inflammatory agent that reduces the body's immune response, while selinexor may have multiple mechanisms of action, including anti-inflammatory and immune-modulating effects."
    }
  },
  "NCT06982079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:46:59.735675Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:46:59.735687Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d56b756fde5890d07d6c381d85b44859",
      "primary_moa": "Sodium-glucose cotransporter 2 (SGLT2) inhibitors primarily exert their therapeutic effects through mechanisms unrelated to the specific pathways listed in the MoA vector. However, the trial's focus on kidney function and cardiovascular outcomes suggests a potential impact on the renin-angiotensin-aldosterone system (RAAS) and vascular health, which may indirectly influence these pathways."
    }
  },
  "NCT05869279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:04.102368Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:04.102374Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a785c2df405c4d7de178ba93825d50bd",
      "primary_moa": "CARCIK-CD19 is an allogeneic CAR T-cell therapy that targets CD19, a surface marker expressed on B-cells. This therapy aims to engraft and expand in patients with B-cell NHL and CLL, potentially leading to remission by modulating the immune system."
    }
  },
  "NCT06920979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:07.995263Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:07.995281Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3a0daa02ffbaf21018b71d5c0c1e761b",
      "primary_moa": "This trial focuses on monitoring and early detection of sepsis, which is a systemic inflammatory response to infection. The primary mechanism of action is likely related to the early identification and management of infections, potentially preventing the progression to sepsis."
    }
  },
  "NCT05788679": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:11.787562Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:11.787574Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "46e89c87ea45b02517a0bd79aafd42d6",
      "primary_moa": "Immunotherapy and DNA Damage Repair"
    }
  },
  "NCT06009679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:15.655932Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:15.655956Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "07cbe3ac0f8e8c0f4feb792edd8b0887",
      "primary_moa": "Misoprostol's primary mechanism of action in this trial is likely related to its role as a prostaglandin E1 analog, which can induce uterine contractions and potentially facilitate the expulsion of retained products of conception."
    }
  },
  "NCT06148779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:19.563065Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:19.563072Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e335c19501acc5c05311042b899be43d",
      "primary_moa": "The trial focuses on comparing the utilization and effectiveness of digital versus face-to-face delivered osteoarthritis (OA) treatment, suggesting a focus on accessibility and delivery methods rather than a specific biological mechanism."
    }
  },
  "NCT06803979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:23.454215Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:23.454256Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6170d06091314b3e1e0b20d9c2d6e135",
      "primary_moa": "The trial focuses on the impact of delivery methods on athletes' performance and pelvic floor stability, suggesting a primary mechanism related to the physiological processes of labor and delivery."
    }
  },
  "NCT06155279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:27.757363Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:27.757369Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ccec738e3a235ca2bb7a917dfcad1f6d",
      "primary_moa": "Immunotherapy (PD-1 inhibitor) in combination with chemotherapy"
    }
  },
  "NCT06476379": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.3,
      "pi3k": 0.2,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.1,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:31.751059Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:31.751074Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "aac7d89ce74f3a676ad8c4397f6b7037",
      "primary_moa": "The study suggests a role of sperm in embryo ploidy determination, indicating a potential impact on DNA integrity and/or cellular signaling pathways."
    }
  },
  "NCT06720779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:35.958239Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:35.958254Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9fc92250c4e1479bd1fbb098dbcd216d",
      "primary_moa": "The trial focuses on the use of a virtual rehabilitation platform in conjunction with a conventional knee rehabilitation program. The primary mechanism of action is likely related to enhancing the effectiveness of conventional therapy through the use of technology, potentially improving adherence and patient outcomes."
    }
  },
  "NCT02945579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.6,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:39.680591Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:39.680627Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8e829dc271dd2b48deabc1dc6a3782df",
      "primary_moa": "HER2 pathway inhibition and Immunotherapy"
    }
  },
  "NCT06881979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:43.837865Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:43.837881Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b35e047578499fc5136f39c782a41336",
      "primary_moa": "The trial focuses on the non-inferiority of high-tech rehabilitation methods compared to traditional rehabilitation in improving balance and reducing fatigue in chronic neuromuscular diseases. It does not specifically target molecular mechanisms like DNA damage repair, MAPK, PI3K/AKT, angiogenesis, HER2, or immunotherapy."
    }
  },
  "NCT06451679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:47.725014Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:47.725034Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "68edac34cb9d51980130a94f1148f68a",
      "primary_moa": "The primary mechanism of action appears to be related to the assessment of dietary intake and its correlation with energy expenditure and hospital stay in hip fracture patients."
    }
  },
  "NCT06363279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:51.519524Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:51.519537Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "04506be29a9e8076300516779fc7a8ca",
      "primary_moa": "The study involves conducting questionnaires to assess a person's tendency to engage in technological interaction, which is not directly related to the mechanisms listed."
    }
  },
  "NCT06098079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:55.323781Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:55.323790Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1e0baee36b86ee4e4415cac3a0b0a54a",
      "primary_moa": "The primary mechanism of action is likely related to the modulation of the neurobiological pathways involved in appetite suppression and weight loss."
    }
  },
  "NCT06944379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:47:59.091649Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:47:59.091681Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1c40934c4fe732d46cff925d30129365",
      "primary_moa": "Pharmacokinetic evaluation in healthy volunteers"
    }
  },
  "NCT05077579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:02.983997Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:02.984002Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "084bbc24abec682ee46c49caccdd8d10",
      "primary_moa": "The trial suggests a focus on the metabolic aspects of obesity and its potential link to Alzheimer's disease, with a specific emphasis on the impact of overweight or obese BMI on cognitive function. While not directly targeting specific molecular pathways, the study aims to understand the underlying mechanisms."
    }
  },
  "NCT06514079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:06.906256Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:06.906262Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b93afd9b11ba1dd969c36cccd8aa6b06",
      "primary_moa": "The primary mechanism of action involves the use of topical steroid injections in conjunction with endoscopic dilatation to treat refractory benign esophageal strictures in children."
    }
  },
  "NCT06069479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:10.706112Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:10.706130Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "325cdffb9158c694d01bc4e1f28e4711",
      "primary_moa": "Craniofacial surgery in children with trigonocephaly may involve the repair of metopic synostosis, which can affect head growth and intracranial pressure."
    }
  },
  "NCT05672459": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:14.441359Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:14.441366Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9d7958cad3025ae769c63212a74acdfa",
      "primary_moa": "Immunotherapy (CAR-T cell therapy targeting HLA-G)"
    }
  },
  "NCT02253251": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:18.550506Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:18.550527Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "63a8880967b8712ce11b8dcd7f0c1366",
      "primary_moa": "The trial focuses on microRNA binding site mutations, which can influence gene expression and potentially impact cancer risk, prevention, and treatment. This suggests a role in gene regulation and cellular processes."
    }
  },
  "NCT05457595": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:22.439334Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:22.439355Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0d01c82b9471151927841ad729d1c62a",
      "primary_moa": "Carbon ion radiation therapy targets DNA damage repair mechanisms, enhancing biological efficacy through higher Linear Energy Transfer (LET) particles."
    }
  },
  "NCT06964009": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.6,
      "pi3k": 0.0,
      "vegf": 0.2,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:26.437302Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:26.437320Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b5cc529ef634e4d0c402e046cf315cce",
      "primary_moa": "DT2216, a proteolysis-targeting chimera degrader of BCL-XL protein, likely targets the MAPK pathway, while Paclitaxel, an antimicrotubule agent, may affect DNA Damage Repair and VEGF-mediated angiogenesis."
    }
  },
  "NCT06103916": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:30.635109Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:30.635122Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3a5f791b1e4e08dcf83fd6ea5f94e125",
      "primary_moa": "The trial focuses on the prospective registration of ultrasound data in patients with ovarian tumors, utilizing the IOTA ADNEX model for diagnostic accuracy. This suggests a strong emphasis on the application of the model rather than a direct mechanism of action."
    }
  },
  "NCT06906341": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.4,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:34.629471Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:34.629488Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e5a7469f21b4d65c3a1feff44cb8d890",
      "primary_moa": "Relacorilant is an aurora kinase inhibitor, which primarily targets the DDR and MAPK pathways."
    }
  },
  "NCT06799637": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.3,
      "pi3k": 0.2,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.1,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:38.685507Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:38.685549Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "66526a27aa57fd2e6bef9d94ec734b23",
      "primary_moa": "XNW28012 is an investigational drug targeting advanced solid tumors that have failed standard treatments. It is designed to overcome resistance mechanisms, likely involving multiple pathways."
    }
  },
  "NCT06639074": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:42.530853Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:42.530870Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cdf9ce2630aa58515fd9bae1157e480a",
      "primary_moa": "Folate Receptor Alpha-based Immunotherapy"
    }
  },
  "NCT05467670": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:46.298416Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:46.298424Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "23c2c29a4225d8c7332cd4e8fecc4d14",
      "primary_moa": "Immunotherapy with immune checkpoint inhibitors and ALX148, an inhibitor of CD47, targeting solid tumors"
    }
  },
  "NCT06800170": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:50.402147Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:50.402161Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6958ac0b105cd73c3a4d3d6c8cd62497",
      "primary_moa": "The primary mechanism of action is likely related to the regulation of the menstrual cycle, possibly through the modulation of hormone levels and the reduction of menstrual cycle irregularities."
    }
  },
  "NCT03067181": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:54.078888Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:54.078896Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bdbe4f4e3a3d089014bab7fc117f8ce1",
      "primary_moa": "Chemotherapy-induced DNA damage and cell cycle arrest"
    }
  },
  "NCT05039801": {
    "moa_vector": {
      "ddr": 0.5,
      "mapk": 0.3,
      "pi3k": 0.0,
      "vegf": 0.2,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:48:58.050488Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:48:58.050493Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4c98a6dd607973550dac499f78f5d109",
      "primary_moa": "The trial involves a glutaminase-1 inhibitor (IACS-6274) which targets the metabolism of cancer cells, potentially affecting DNA damage repair and cell proliferation."
    }
  },
  "NCT06032975": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:01.712160Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:01.712199Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cf4dc806cfa95d27e5c53018bc3f1c10",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT05403177": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.4,
      "pi3k": 0.2,
      "vegf": 0.1,
      "her2": 0.2,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:05.349754Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:05.349773Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "986cb415c45cf7e0fc40d1c192c605a6",
      "primary_moa": "Precision medicine approach targeting various cancer pathways"
    }
  },
  "NCT05281471": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:09.339017Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:09.339034Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b5ae2621f977120c4c20294ef545a33a",
      "primary_moa": "The primary mechanism of action involves the VEGF pathway inhibition and Immunotherapy."
    }
  },
  "NCT02914158": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:13.011522Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:13.011536Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6a4e448eda8c939bc25de69b07810bc3",
      "primary_moa": "Endocrine therapy targeting hormone receptors and ovarian suppression"
    }
  },
  "NCT06852365": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.3,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:16.800339Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:16.800348Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b1b4f9e0baf85bbd5a59b0eea3f11054",
      "primary_moa": "The primary mechanism of action appears to be the modulation of the gut microbiome and its impact on cardiometabolic parameters, potentially through the use of resistant starch."
    }
  },
  "NCT01174121": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:20.556766Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:20.556771Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "14a90c8b3bffbd74ca68637eb26c33bf",
      "primary_moa": "Immunotherapy using Tumor Infiltrating Lymphocytes (TIL) to stimulate the patient's immune system to recognize and attack cancer cells."
    }
  },
  "NCT05855941": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:24.719449Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:24.719466Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a26dc382a21929e795bcbcfa833efc93",
      "primary_moa": "The trial focuses on the diagnostic and prognostic value of advanced medical imaging, particularly FDG-PET/CT and FDG-PET/MRI, in gynecological cancer. These imaging techniques are used to assess tumor metabolism and activity, which can provide insights into cancer progression and response to treatment. While not directly targeting specific molecular pathways, the primary mechanism involves the use of advanced imaging to detect and monitor cancer progression, which can influence treatment decisions and patient outcomes."
    }
  },
  "NCT06378905": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.2,
      "pi3k": 0.1,
      "vegf": 0.7,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:28.662186Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:28.662193Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7e350e00bdd1c44bc2dff06e4e0013c5",
      "primary_moa": "Epithelial ovarian cancer treatment likely involves a combination of DNA damage repair inhibition, angiogenesis inhibition, and immunotherapy."
    }
  },
  "NCT04969835": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:32.542642Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:32.542658Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d18d56b829871d1d7412433c4a18c925",
      "primary_moa": "AVA6000 is a novel targeted therapy that primarily acts by inhibiting DNA Damage Repair (DDR) pathways, specifically PARP, ATR, and ATM, leading to cell cycle arrest and apoptosis in tumor cells."
    }
  },
  "NCT07159880": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:36.787635Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:36.787671Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8931865ffebe47d78a85a244af81b936",
      "primary_moa": "Letrozole is an aromatase inhibitor that primarily acts by inhibiting the conversion of androgens to estrogens, which is a key mechanism in the management of PCOS."
    }
  },
  "NCT03458221": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:40.414970Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:40.414994Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a39b2970e6d09d88923c4b603e530b36",
      "primary_moa": "Targeted therapy based on functional signal transduction pathway activity"
    }
  },
  "NCT06380816": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:44.312545Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:44.312553Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "10be98454998926ca9363cf193072bad",
      "primary_moa": "Immunotherapy (HLA-G targeting to enhance immune response against cancer cells)"
    }
  },
  "NCT06883487": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 1.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:45.012772Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:45.012789Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d89dd1516aaf190303f1f3e6c2ecaae9",
      "primary_moa": "HER2 pathway activation through ADC targeting"
    }
  },
  "NCT06508307": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:48.751220Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:48.751239Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1695d705ec1e409172b691896c527fc5",
      "primary_moa": "Oncolytic Virotherapy"
    }
  },
  "NCT06251310": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:52.759164Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:52.759171Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "026d8824115096f3ca54eb3037a09bc0",
      "primary_moa": "No clear mechanism of action identified."
    }
  },
  "NCT06016062": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:49:56.752951Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:49:56.752988Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d92be6af4ac4b21cc4c551a0b386b9ef",
      "primary_moa": "This trial primarily focuses on evaluating the safety, tolerability, and efficacy of RC148, a potential anti-cancer agent, in various combination therapies with other drugs."
    }
  },
  "NCT07151391": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:00.546391Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:00.546415Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dcedd0cc0bbed5056150d3e6fce033d6",
      "primary_moa": "Guarana may have a general restorative effect on patients with cancer-related fatigue, potentially through multiple mechanisms."
    }
  },
  "NCT06232863": {
    "moa_vector": {
      "ddr": 0.5,
      "mapk": 0.3,
      "pi3k": 0.2,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:04.335891Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:04.335904Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3b89cf42f3702b5e174c854e9e2fff0e",
      "primary_moa": "BH009 is an investigational drug that targets multiple mechanisms in cancer cells, including DNA damage repair and immunotherapy."
    }
  },
  "NCT05123040": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:08.320954Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:08.320963Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0270711efc6897254f49b28c37ce583f",
      "primary_moa": "The trial involves a combination of corticosteroids, ruxolitinib, and uhCG/EGF for the treatment of high-risk aGVHD. The primary mechanism of action is likely related to immunosuppression and anti-inflammatory effects, rather than a specific molecular pathway."
    }
  },
  "NCT05797168": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.2,
      "pi3k": 0.1,
      "vegf": 0.3,
      "her2": 0.0,
      "io": 0.1,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:12.179968Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:12.180000Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4e190f862626212b13ef4c64c8e938fb",
      "primary_moa": "Antibody-drug conjugate therapy targeting solid tumors, with potential involvement of DNA damage repair and angiogenesis pathways."
    }
  },
  "NCT05200559": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:16.007653Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:16.007668Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3c0a041abbf1a8f66755d9a134ac837c",
      "primary_moa": "Immunotherapy (PD-1, PD-L1 inhibitors) with T-regulatory cell depletion"
    }
  },
  "NCT06014190": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:19.911405Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:19.911415Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5f60f26ea765af1ffb510a840e09ee81",
      "primary_moa": "Antibody-drug conjugate targeting B7-H4 with topoisomerase I inhibitor payload"
    }
  },
  "NCT05329662": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:23.682009Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:23.682023Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "79cb943f646dbaf47d7fc1e1b012bce9",
      "primary_moa": "Hormone Therapy"
    }
  },
  "NCT05952453": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:27.778205Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:27.778216Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c48ce6628aa06d3f2a975ca3c079793b",
      "primary_moa": "DNA Damage Repair (PARP, ATR, ATM, CHK1/2, WEE1 inhibitors) and Immunotherapy (PD-1, PD-L1, CTLA-4 inhibitors)"
    }
  },
  "NCT06242470": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:31.771976Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:31.771987Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9340ec918501c4084e533529dd253abf",
      "primary_moa": "No clear mechanism identified"
    }
  },
  "NCT06465069": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:35.584753Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:35.584772Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "edec9c17090e2de8248bb8c5b9c45195",
      "primary_moa": "LY4052031 is an investigational drug that may target multiple mechanisms, including DNA damage repair and immunotherapy."
    }
  },
  "NCT06154291": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:39.247143Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:39.247157Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8c833f1ef8b82ac1a32b06bfe7d8ceef",
      "primary_moa": "DNA Damage Repair and Immunotherapy"
    }
  },
  "NCT04758000": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:42.996529Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:42.996543Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bff084e3b797f59b4d9a79b11eef27a4",
      "primary_moa": "No clear mechanism identified"
    }
  },
  "NCT04038502": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:46.742472Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:46.742487Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a5507e868e342054b2a0c4cdea5cd0fb",
      "primary_moa": "DNA Damage Repair (DDR) with potential involvement of Immunotherapy (IO)"
    }
  },
  "NCT06014528": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.2,
      "pi3k": 0.4,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:50.617776Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:50.617808Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e473220f9760e71271e6a32f1b3dc8de",
      "primary_moa": "IN10018 likely targets the DNA Damage Repair pathway, with potential involvement in the PI3K/AKT pathway, and may have an indirect effect on Immunotherapy through its combination with Pegylated Liposomal Doxorubicin."
    }
  },
  "NCT06293898": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:54.404882Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:54.404897Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ed163f4841733c43e6a883d3fb68aadf",
      "primary_moa": "HER2 pathway inhibition"
    }
  },
  "NCT05691504": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.6,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:50:58.213441Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:50:58.213446Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0475039c16dbc31267493e88fa9464df",
      "primary_moa": "The primary mechanism of action involves the inhibition of the RAS/MAPK pathway (BRAF, MEK, KRAS inhibitors) and the inhibition of proteins that prevent cell death (APG-1252)."
    }
  },
  "NCT05976308": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:01.931998Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:01.932013Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5dc70b5210365f6f21e2e214a19c08a4",
      "primary_moa": "Immunomodulatory effects"
    }
  },
  "NCT06238479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:05.716588Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:05.716622Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "50d7eb88ac88d1554c7b36765c977f84",
      "primary_moa": "LY4101174 is an investigational drug targeting advanced or metastatic solid tumors, suggesting a focus on cancer cell growth and survival pathways."
    }
  },
  "NCT06547840": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:09.511046Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:09.511063Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e2053a8f74d88303d6bbd7f62db0e64a",
      "primary_moa": "The study does not provide specific information about the primary mechanism of action, but it suggests a focus on immunotherapy and potentially drug efflux mechanisms."
    }
  },
  "NCT06023862": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:13.533859Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:13.533876Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9c8c6cd2e73ea728546744153dbdb001",
      "primary_moa": "Angiogenesis and Immunotherapy"
    }
  },
  "NCT07023484": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.3,
      "pi3k": 0.2,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.1,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:17.274647Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:17.274653Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f04157509df739ae5b3e555c719672c8",
      "primary_moa": "Neoadjuvant chemotherapy followed by interval debulking surgery, utilizing CA125 kinetic changes to guide timing."
    }
  },
  "NCT05759923": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:21.254259Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:21.254362Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0432af8cccff1c33e5d4068a31dc0802",
      "primary_moa": "OATD-02 may enhance tumour responses to immunotherapy through increased arginine levels or intrinsic anti-tumour activity."
    }
  },
  "NCT06494150": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:25.144826Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:25.144840Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bee784a5224393c3e6a6b1c1a9a3cb25",
      "primary_moa": "This trial combines a mTOR inhibitor (nab-sirolimus) with endocrine therapy (Fulvestrant), targeting the PI3K/AKT/mTOR pathway and estrogen receptor signaling, respectively."
    }
  },
  "NCT04633239": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:29.178546Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:29.178552Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b7af34ae29e9f10373d11c4c85642289",
      "primary_moa": "Abemaciclib, an ATR inhibitor, targets DNA damage repair pathways, while Olaparib, a PARP inhibitor, enhances DNA damage response. This combination therapy aims to inhibit DNA repair mechanisms, potentially leading to cell cycle arrest and apoptosis in cancer cells."
    }
  },
  "NCT05489211": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.4,
      "pi3k": 0.3,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:33.076945Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:33.076968Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7ca8256f96f5c8fe976725d4ecea964e",
      "primary_moa": "Datopotamab deruxtecan (Dato-DXd) is an antibody-drug conjugate targeting topoisomerase I, which can induce DNA damage and cell death. It may also affect the MAPK and PI3K/AKT pathways."
    }
  },
  "NCT06526819": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.3,
      "pi3k": 0.2,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.1,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:36.692491Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:36.692508Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5c80a2ba8a6d65c580593de3111b7cbe",
      "primary_moa": "Antitumor activity, likely through multiple mechanisms"
    }
  },
  "NCT05255471": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:40.318604Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:40.318637Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ed6f022f5c33ab730172f963f85dc628",
      "primary_moa": "PARP inhibitor-based DNA damage repair inhibition"
    }
  },
  "NCT06533332": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:44.270624Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:44.270632Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d72e632a44ac129e4773dd2e220c4f6d",
      "primary_moa": "No clear mechanism of action identified."
    }
  },
  "NCT06774963": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:48.472201Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:48.472212Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "67d137402a17c18f46f116eea986ee77",
      "primary_moa": "LNCB74 is an experimental drug, and the trial does not specify a clear mechanism of action. However, based on the conditions and the phase of the trial, it is likely targeting multiple pathways."
    }
  },
  "NCT07125391": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.4,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:52.565275Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:52.565284Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "76b0bedbe6ef78c1e61f46ccbdb61ac2",
      "primary_moa": "Chemotherapy combined with propranolol hydrochloride may target multiple mechanisms, including DNA damage repair, angiogenesis inhibition, and potentially immunotherapy."
    }
  },
  "NCT06533059": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.0,
      "pi3k": 0.7,
      "vegf": 0.2,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:51:56.458781Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:51:56.458817Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "48539efe74394de5c845f1743dc46fe4",
      "primary_moa": "ALTA2618 is an AKT inhibitor, targeting the PI3K/AKT pathway, with potential secondary effects on DNA damage repair and angiogenesis."
    }
  },
  "NCT06666270": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:00.142953Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:00.142967Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e7a600f3db04c772f3fa577a20168647",
      "primary_moa": "Immunotherapy and anti-angiogenesis"
    }
  },
  "NCT06843447": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.2,
      "pi3k": 0.1,
      "vegf": 0.3,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:03.759090Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:03.759097Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cc24265d3ac3f835472ecbe9b719fd3f",
      "primary_moa": "Chemotherapy-induced DNA damage and subsequent immune activation"
    }
  },
  "NCT06466187": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:07.723423Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:07.723430Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c02e42e279784d1a4b73f5eb5bf82b46",
      "primary_moa": "This trial focuses on advanced solid tumors, which can be considered as a broad category of cancer types. The primary mechanism of action is likely related to the inhibition of tumor growth and progression, which can be achieved through multiple pathways."
    }
  },
  "NCT05737303": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:11.474308Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:11.474325Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f6f93ae069f07e0983888f599ec54a57",
      "primary_moa": "Taxane-based chemotherapy targeting microtubules"
    }
  },
  "NCT06781983": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.3,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:15.511055Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:15.511064Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "37164121665005dd86cc1116b3e1e6e7",
      "primary_moa": "IPH4502 is an inhibitor targeting Nectin-4, a protein expressed in advanced solid tumors, suggesting a mechanism of action related to tumor cell targeting and potential immune modulation."
    }
  },
  "NCT03842982": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:19.396529Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:19.396541Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3db6df39e771c712fc6f2cf26d419433",
      "primary_moa": "HIPEC is a form of hyperthermic chemotherapy that involves the direct application of heated chemotherapy drugs into the peritoneal cavity, targeting the tumor microenvironment and enhancing drug delivery and efficacy."
    }
  },
  "NCT06047379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:23.185054Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:23.185070Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d6d10dcb71e01464132a1bece89891c8",
      "primary_moa": "Immunotherapy and Angiogenesis"
    }
  },
  "NCT06682988": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:27.003533Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:27.003552Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3d79ba3beb80730abcb42d236b2cd72f",
      "primary_moa": "Mirvetuximab Soravtansine targets the FR\u03b1 protein, which is overexpressed in platinum-resistant ovarian cancer cells, leading to their selective killing and reduced tumor growth."
    }
  },
  "NCT05804370": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:30.974480Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:30.974494Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5d3ee816fd56967e72ef5bf95ce21e43",
      "primary_moa": "Gleolan is an MRI contrast agent that enhances the visualization of tumor tissue during surgery, potentially aiding in the detection and resection of ovarian cancer."
    }
  },
  "NCT05128825": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:34.814220Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:34.814232Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4a0053867b92f293f00f3215e1f9200a",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT06953089": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:38.698632Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:38.698650Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a8c7f554b8b1fd54b54a8f164396c636",
      "primary_moa": "Combination therapy targeting multiple pathways"
    }
  },
  "NCT06842524": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:42.644871Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:42.644888Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cc8f4846151b7d1eccaf1424e663c4db",
      "primary_moa": "Not specified"
    }
  },
  "NCT05902988": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:46.737524Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:46.737540Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "28f35621570c241c6f8916d0ec08c60d",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT03651206": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.4,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:50.749453Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:50.749487Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "fc0f5f47abe788e36cf66159eb9bc0c2",
      "primary_moa": "Immunotherapy (PD-1 inhibitor) in combination with DNA Damage Repair (PARP inhibitor) and targeted therapy (VEGF inhibitor)"
    }
  },
  "NCT07213804": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.2,
      "pi3k": 0.3,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:54.752926Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:54.752933Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "723498720123a5a913474a263d104040",
      "primary_moa": "LY4170156 is an ATR inhibitor, targeting DNA Damage Repair (DDR) pathways, with potential secondary effects on the PI3K/AKT pathway."
    }
  },
  "NCT06412510": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:55.748529Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:55.748536Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b35dde41b56dd61f646c60b0758462d2",
      "primary_moa": "Prehabilitation focuses on exercise and nutrition to improve patients' physical and nutritional status, potentially enhancing their ability to tolerate cancer treatment and surgery."
    }
  },
  "NCT05327010": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:52:59.578079Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:52:59.578139Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "54d902b133e5eda98a11523afb3e6309",
      "primary_moa": "DNA Damage Repair (DDR) and Immunotherapy (IO)"
    }
  },
  "NCT03564340": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:03.537730Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:03.537735Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "182c12a1ee074054665e37336133fb87",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT05950464": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.6,
      "pi3k": 0.4,
      "vegf": 0.4,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:07.414050Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:07.414069Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e35f3b9837831e315c649d4c4722bccb",
      "primary_moa": "The primary mechanism of action involves the inhibition of cell growth and angiogenesis through the combined use of M1774 and ZEN-3694."
    }
  },
  "NCT03755739": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:11.212185Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:11.212208Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1cb8695af7ecb357581bbce8e4e957c4",
      "primary_moa": "Immunotherapy with checkpoint inhibitors and angiogenesis inhibition"
    }
  },
  "NCT07023731": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 1.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:15.001873Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:15.001895Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "200b5eb288aa1b69a855bd5895037adb",
      "primary_moa": "ARV-806 is designed to target the KRAS G12D mutation, which is a specific protein mutation present in some tumors. This mechanism is likely the primary focus of the trial."
    }
  },
  "NCT06152731": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.2,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:18.992242Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:18.992248Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0e4ab771504bfdbdca83933ae025c63f",
      "primary_moa": "DNA Damage Repair (DDR) pathway activation, potentially leading to PARP inhibitor treatment."
    }
  },
  "NCT06468254": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.3,
      "pi3k": 0.2,
      "vegf": 0.5,
      "her2": 0.1,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:22.985535Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:22.985542Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0e8319cee71becdeeb40e62fc35adbb9",
      "primary_moa": "Statins may enhance the efficacy of chemotherapy and maintenance therapy in ovarian cancer by modulating multiple pathways, including DNA damage repair, angiogenesis, and potentially immunotherapy."
    }
  },
  "NCT06238687": {
    "moa_vector": {
      "ddr": 0.5,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:26.880778Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:26.880791Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "fe0ac90721c4f3642c7ac470b7b528d5",
      "primary_moa": "STRO-002 is an investigational agent that may target multiple mechanisms, including DNA damage repair and immunotherapy."
    }
  },
  "NCT06469281": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:30.768157Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:30.768165Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "40ca3cfcb67745b1952d34fe4026fcb5",
      "primary_moa": "The primary mechanism of action is likely related to angiogenesis inhibition (VEGF) and immunotherapy (PD-1/PD-L1 inhibitors)."
    }
  },
  "NCT00722228": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:34.716959Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:34.716976Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f1a4a082b31998076bd512cc08875600",
      "primary_moa": "Immunotherapy"
    }
  },
  "NCT05394142": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.4,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:38.728072Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:38.728088Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "69df126a381dd436fde28cd1252d1e05",
      "primary_moa": "Metformin and Pioglitazone target the PI3K/AKT pathway, while Spironolactone may modulate the mineralocorticoid receptor, potentially affecting the MAPK pathway."
    }
  },
  "NCT06910657": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:42.752479Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:42.752496Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e79cf575861a1a4714f9ebeb1c98b489",
      "primary_moa": "Oncolytic virus therapy targeting cancer cells and stimulating the immune system"
    }
  },
  "NCT02637934": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:47.364316Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:47.364333Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "138f478edfaa04dd201787427cf1cb10",
      "primary_moa": "The primary mechanism of action appears to be related to the evaluation of a novel radiotracer [18F]FluorThanatrace (FTT) for imaging gynecological cancer, potentially involving its biodistribution and uptake."
    }
  },
  "NCT06305299": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:51.356415Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:51.356429Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f4eeba71ea5ba0913d25f67b16afc528",
      "primary_moa": "Immunotherapy (CAR-T cell therapy targeting a specific antigen)"
    }
  },
  "NCT07158021": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:55.345233Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:55.345267Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "86cf56569eb971fbcead3d5c7b111410",
      "primary_moa": "Estrogen suppression to inhibit tumor cell growth"
    }
  },
  "NCT06234423": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:53:59.294623Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:53:59.294639Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "70248ed56817e8862fc77bf06c07f838",
      "primary_moa": "CUSP06 is an investigational agent targeting DNA Damage Repair pathways, with potential implications for platinum-refractory/resistant ovarian cancer and other advanced solid tumors."
    }
  },
  "NCT05998135": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:03.229904Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:03.229912Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4d14c466c85a5f843632fe28d75cfb2c",
      "primary_moa": "Atovaquone's antiprotozoal properties may contribute to its potential efficacy in treating platinum-resistant ovarian cancer by targeting protozoa-related mechanisms."
    }
  },
  "NCT05208762": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:06.983443Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:06.983456Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "aa72d27f839103e36b40b3fb5d01cc32",
      "primary_moa": "Immunotherapy (PD-1, PD-L1 inhibitors)"
    }
  },
  "NCT06556108": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:10.658440Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:10.658459Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a29afa1b99bef554b99d5347ac1bb520",
      "primary_moa": "Immunotherapy (CAR-T cell therapy)"
    }
  },
  "NCT06979596": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:14.392397Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:14.392410Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ead3b5667746932abb769a436e4c5de9",
      "primary_moa": "Hormone Therapy"
    }
  },
  "NCT05065021": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "No",
      "pi3k": "No",
      "vegf": "No",
      "her2": "No",
      "io": "Yes",
      "efflux": "No"
    },
    "confidence": "Medium",
    "primary_moa": "IO",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.174017",
      "source_checksum": "26d18b6ef4fb419b36f9e33ec8ea2728",
      "source": "llm_batch_tagging"
    }
  },
  "NCT06954584": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:22.484202Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:22.484217Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2724c345241c769f7c772690f19dd00d",
      "primary_moa": "The primary mechanism of action involves the combination of PARP inhibitors (Fluzoparib) and anti-angiogenic agents (Bevacizumab) to enhance tumor cell sensitivity and inhibit angiogenesis."
    }
  },
  "NCT06045260": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:26.298717Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:26.298730Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2beb1673bd0c1aae77d752176091004c",
      "primary_moa": "Receptor Radionuclide Therapy targeting GEP-NETs"
    }
  },
  "NCT03675893": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:30.164088Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:30.164096Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e027b9ecbe9fbb58aadd49fc0f30aad1",
      "primary_moa": "This trial focuses on a combination of targeted therapies, primarily targeting the estrogen-receptor positive (ER+) pathway, with no clear indication of a specific primary mechanism."
    }
  },
  "NCT03878849": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:34.005022Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:34.005032Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f608a8232d64cc446745bb27ea1e5505",
      "primary_moa": "The primary mechanism of action is likely related to DNA Damage Repair (DDR) pathways, as the trial focuses on evaluating the optimal dose of 2X-121, a potential DDR inhibitor, in patients with platinum-resistant ovarian cancer."
    }
  },
  "NCT06504147": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:37.953232Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:37.953270Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cbd7b723f48fec0cbb147b2ae5191f76",
      "primary_moa": "Radspherin is an anti-cancer agent that targets DNA damage repair pathways, specifically homologous recombination proficient cells."
    }
  },
  "NCT05763199": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:41.639017Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:41.639026Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "49e6a6096bb5d7f7b5fcc65dee64b3a7",
      "primary_moa": "AHCC may enhance the efficacy of chemotherapy by modulating immune responses and reducing drug resistance."
    }
  },
  "NCT06732336": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 1.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:45.430663Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:45.430678Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "500737bd861ab5a2b386e5af37cd1dea",
      "primary_moa": "HER2 pathway targeting with 89Zr-trastuzumab"
    }
  },
  "NCT03275194": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:49.580121Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:49.580133Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3324ecd9c0bfb232e6c964af4fc4d265",
      "primary_moa": "HIPEC is a hyperthermic intraperitoneal chemotherapy that targets the microenvironment of the tumor, potentially affecting multiple cellular processes."
    }
  },
  "NCT05969041": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:53.716935Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:53.716954Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ca5f25edc458742cab91ecca236b20d3",
      "primary_moa": "MT-302 is an investigational agent designed to target epithelial cancer cells, likely through a combination of mechanisms including DNA damage repair inhibition and immunomodulation."
    }
  },
  "NCT07156253": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:54:57.711564Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:54:57.711576Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b45ff5fc6a35e18e1374edac7f2395e9",
      "primary_moa": "This trial combines a PARP inhibitor (Olaparib) with a novel agent (SYN818), suggesting a focus on DNA Damage Repair (DDR) mechanisms."
    }
  },
  "NCT05233982": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:01.449343Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:01.449397Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2f4531e73ff6ee2c5f6cb32c06eddd9e",
      "primary_moa": "Olaparib is a PARP inhibitor, which primarily targets the DNA Damage Repair (DDR) pathway, making it a key mechanism of action for this trial."
    }
  },
  "NCT05005403": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.2,
      "pi3k": 0.2,
      "vegf": 0.6,
      "her2": 0.1,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:05.668520Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:05.668533Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "258b7feec72e620e9900a22db9c62855",
      "primary_moa": "The primary mechanism of action appears to be a combination of angiogenesis inhibition and immunotherapy, with potential involvement of DNA damage repair and the PI3K/AKT pathway."
    }
  },
  "NCT06926075": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:09.485083Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:09.485098Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a8cdf417fc25652b7aed2b24e3f506d9",
      "primary_moa": "Kesonotide is a novel vimentin inhibitor, suggesting a primary mechanism of action targeting cell growth and survival pathways."
    }
  },
  "NCT06743867": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:13.379056Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:13.379071Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ef3786e0085c233f6b622933904cb8b5",
      "primary_moa": "The trial focuses on the delivery of chemotherapy through a novel nebulized drug delivery system for peritoneal metastatic adenocarcinoma, which suggests a primary mechanism of targeted drug delivery to the tumor site."
    }
  },
  "NCT05277051": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:17.369217Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:17.369225Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9ea5ce432bab410e39e0dc15dc075443",
      "primary_moa": "Immunotherapy (PD-1, PD-L1 inhibitors)"
    }
  },
  "NCT04851119": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:21.569743Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:21.569749Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c9dc922ffdf23f990a316bf0aa7c5866",
      "primary_moa": "Tegavivint interferes with the binding of beta-catenin to TBL1, potentially blocking tumor cell growth signals."
    }
  },
  "NCT04956640": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:25.874369Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:25.874410Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8d520b3060533fa26b04ea7805d47ce5",
      "primary_moa": "LY3537982 is a targeted therapy that inhibits the KRAS G12C mutation, which is a key driver of cancer progression. This trial focuses on the efficacy of LY3537982 in cancer patients with this specific genetic mutation."
    }
  },
  "NCT05467891": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:29.963275Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:29.963283Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "43fa1dde380a9d72a8a6bc2c08b32f69",
      "primary_moa": "Ribociclib is an inhibitor of CDK4 and CDK6, which are key regulators of the cell cycle. It is used in combination with endocrine therapy to treat HR-positive, HER2-negative breast cancer."
    }
  },
  "NCT06315491": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:33.615564Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:33.615575Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a1df7d5e55258af1881c088617fa1183",
      "primary_moa": "No clear mechanism identified"
    }
  },
  "NCT05500391": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:37.890672Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:37.890695Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6066c7306d397c532141a3b5c9ab5b56",
      "primary_moa": "The trial focuses on compliance with post-treatment surveillance plans, which is not directly related to specific molecular mechanisms like DDR, MAPK, PI3K, VEGFR, HER2, or IO. The primary mechanism is the adherence to a medical protocol."
    }
  },
  "NCT05891093": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:42.068577Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:42.068588Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "610a318f3db397efdf9340c4f936e26d",
      "primary_moa": "DNA Damage Repair (DDR) and Immunotherapy"
    }
  },
  "NCT05605119": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:46.163067Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:46.163083Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "65f800beda7ae0b81a72e7115370b1ad",
      "primary_moa": "AUR105 is an investigational agent designed to target advanced malignancies, likely through multiple mechanisms."
    }
  },
  "NCT05472857": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:49.841686Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:49.841701Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "29d405a6d5487bb94b956722766c9c8b",
      "primary_moa": "Immunotherapy (CAR-T cell therapy)"
    }
  },
  "NCT06468098": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:53.650971Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:53.650979Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b69373a8b8299efedf855e1ec9619423",
      "primary_moa": "IBI363 is an investigational agent that may target multiple mechanisms, including DNA damage repair and immunotherapy."
    }
  },
  "NCT06836128": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:55:57.546851Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:55:57.546883Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a874c634743e5a36be927ef57285b31d",
      "primary_moa": "The trial suggests a focus on metabolic and hormonal effects, potentially involving the PI3K/AKT pathway and drug efflux mechanisms."
    }
  },
  "NCT06297525": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:02.072676Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:02.072684Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cdbd98208dc2f5929f814ddea96e9620",
      "primary_moa": "DNA Damage Repair (DDR) and Immunotherapy (IO)"
    }
  },
  "NCT06630325": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:05.803204Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:05.803219Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3219d849e08a22d0c14205a853b26277",
      "primary_moa": "No clear mechanism identified"
    }
  },
  "NCT04503278": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:09.524222Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:09.524232Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dde12334d5deec3ddc9ce391b7530fd9",
      "primary_moa": "Immunotherapy (CAR-T cell therapy and RNA-based vaccine combination)"
    }
  },
  "NCT05903807": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.7,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:10.419976Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:10.419984Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d491bc5b709f5ee84d67639b93911510",
      "primary_moa": "FAPI-46 is an anti-tumor agent that targets the HER2 pathway, with potential implications for DNA damage repair and immunotherapy."
    }
  },
  "NCT06330064": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 1.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:14.804447Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:14.804522Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "46d437b49fc55df15a9ab2894d49bbad",
      "primary_moa": "Ifinatamab deruxtecan is an antibody-drug conjugate (ADC) that targets the HER2 protein, which is overexpressed in certain cancers. It delivers a potent chemotherapeutic payload to cancer cells, leading to cell death and tumor regression."
    }
  },
  "NCT05879926": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:19.677711Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:19.677722Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d5aea5b5586213c8610e9024a62b4719",
      "primary_moa": "This trial focuses on adjuvant chemotherapy and endocrine therapy, with no clear indication of a specific mechanism of action. The primary goal is to improve invasive breast cancer-free survival."
    }
  },
  "NCT03059173": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:23.663573Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:23.663662Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3e35ebc4fa19006440d982122419ef2e",
      "primary_moa": "The primary mechanism of action appears to be the modulation of the endocrine system, specifically targeting the PCOS condition and its response to ovulation induction."
    }
  },
  "NCT05955105": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.2,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:27.734915Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:27.734928Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "89957f7a215f22163198c106ad623de2",
      "primary_moa": "Immunotherapy (PD-1, PD-L1 inhibitors) with potential DNA Damage Repair (PARP, ATR, ATM, CHK1/2, WEE1 inhibitors) and Angiogenesis (VEGF, VEGFR inhibitors, bevacizumab) components"
    }
  },
  "NCT06173037": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:31.851082Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:31.851088Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1a1eb882a544254b880f8b08d4025b6b",
      "primary_moa": "DNA Damage Repair (DDR) and Immunotherapy"
    }
  },
  "NCT06994195": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.2,
      "pi3k": 0.1,
      "vegf": 0.3,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.1
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:35.818740Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:35.818751Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a96733af997eddced5050f4512d29bb0",
      "primary_moa": "BL-B01D1 is an investigational drug targeting DNA Damage Repair (DDR) pathways, with potential secondary effects on angiogenesis and drug efflux."
    }
  },
  "NCT07029399": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:39.676052Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:39.676091Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "224ec69043cbe4c6d6793d54702e2bb6",
      "primary_moa": "CDK2/CDK4 dual degradation targeting cell cycle progression and tumor growth"
    }
  },
  "NCT06787612": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.2,
      "pi3k": 0.1,
      "vegf": 0.4,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:43.537247Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:43.537256Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0280fdf0b47c80dd3fe1b0b91cd382ee",
      "primary_moa": "Combination therapy targeting multiple pathways for cancer treatment"
    }
  },
  "NCT05123807": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:47.968727Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:47.968742Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "72e18770cd5d27ac4da26951f366392b",
      "primary_moa": "The trial focuses on cytoreductive surgery combined with HIPEC, which targets the removal of visible disease and the delivery of high-dose chemotherapy directly to the peritoneal cavity. This approach is designed to maximize the reduction of tumor cells and potentially improve survival in recurrent mucinous ovarian cancer."
    }
  },
  "NCT05733000": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:52.114993Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:52.115004Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2631fa8c9aa4697eec5ef2132fa493ab",
      "primary_moa": "CPI-613 (Devimistat) is an inhibitor of the pentose phosphate pathway, which is a metabolic pathway involved in the production of NADPH, a cofactor essential for cell growth and division. This mechanism is likely the primary MoA of CPI-613."
    }
  },
  "NCT06686030": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:56:56.033975Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:56:56.033990Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "875df629fb1e7daaa5d37cb614d6da80",
      "primary_moa": "Combination therapy of AK112 with chemotherapy and/or olaparib targets DNA damage repair and immune modulation in platinum-sensitive ovarian cancer."
    }
  },
  "NCT06431594": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.8,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:00.743647Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:00.743673Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2d88dfc912f8a4378d551bf1243aea03",
      "primary_moa": "GSK5733584 is an investigational drug that is being evaluated for its safety, tolerability, pharmacokinetics, and clinical activity in participants with advanced solid tumors. The primary mechanism of action is likely related to its impact on the PI3K/AKT pathway, as this pathway is frequently dysregulated in cancer and is a common target for cancer therapy."
    }
  },
  "NCT05568680": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:04.671282Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:04.671307Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "47bc1c80eddfde40a99645f60b6f1f7c",
      "primary_moa": "Immunotherapy with CAR-T cells targeting mesothelin"
    }
  },
  "NCT04701645": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:09.002501Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:09.002516Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "efaf7ef1f250cb739f50e8334a0ab084",
      "primary_moa": "The primary mechanism of action is likely related to the implantable microdevice's ability to measure local intratumor response to chemotherapy and other drugs, which may involve multiple pathways."
    }
  },
  "NCT03556228": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:12.787364Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:12.787379Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e3d59bf8a43d911caf08b122d11afaab",
      "primary_moa": "VMD-928 is a TrkA inhibitor, targeting the TrkA receptor, which is overexpressed in certain solid tumors and lymphomas."
    }
  },
  "NCT05861830": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:16.485170Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:16.485176Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "aecaad3a1766e3f8f2689bf4cf1b98c6",
      "primary_moa": "Combination therapy targeting CDK4/6 inhibitor resistance through multiple pathways"
    }
  },
  "NCT06690775": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.7,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:20.373116Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:20.373124Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "14ae8a7c9c0eda800956f27b341906a7",
      "primary_moa": "TORL-1-23 is an anti-angiogenesis agent targeting VEGFR, with potential secondary effects on DNA damage repair and immune modulation."
    }
  },
  "NCT06395519": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:24.215323Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:24.215330Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "eae6d5760705e1ad61829379a8242549",
      "primary_moa": "PARP inhibitor targeting DNA damage repair"
    }
  },
  "NCT04282044": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:28.842968Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:28.843048Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bd0a37678e406689679d099436914e30",
      "primary_moa": "Immunotherapy and DNA Damage Repair"
    }
  },
  "NCT04804007": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:32.793533Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:32.793548Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3a645bd08534f6532208089d1f6a9d56",
      "primary_moa": "DNA Damage Repair and Immunotherapy"
    }
  },
  "NCT07213791": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:36.537039Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:36.537060Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0dcc98000ccd447462b80beea0b43bf3",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT07118176": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.5,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:40.550056Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:40.550063Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5dc97c73a13af9ff18339c3db0bdc7b5",
      "primary_moa": "The primary mechanism of action is likely related to the imaging tracer's ability to accumulate in cancer tissues, which may provide insights into tumor metabolism and vascularization."
    }
  },
  "NCT06483048": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:44.671723Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:44.671733Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5546e8192694215abe7a24b6a87b9257",
      "primary_moa": "Immunotherapy (T-cell activation)"
    }
  },
  "NCT05585281": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:48.416354Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:48.416395Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "da6e614eccbb762b81d1b20f9e399b7e",
      "primary_moa": "DNA Damage Repair (DDR) and Immunotherapy"
    }
  },
  "NCT03287271": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.8,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:53.094541Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:53.094548Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "657b19bed1cd725b3a6d88f648adcffe",
      "primary_moa": "The primary mechanism of action involves the inhibition of the PI3K/AKT pathway, as indicated by the use of VS-6063, which targets FAK (focal adhesion kinase)."
    }
  },
  "NCT04516447": {
    "moa_vector": {
      "ddr": 0.3,
      "mapk": 0.2,
      "pi3k": 0.1,
      "vegf": 0.4,
      "her2": 0.0,
      "io": 0.1,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:57:58.215745Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:57:58.215751Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4dc16f04250cf9a42ffc02364ec250b2",
      "primary_moa": "Combination therapy targeting multiple pathways for cancer treatment"
    }
  },
  "NCT07216105": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.6,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:02.553936Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:02.553996Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f091bb89061746673988e274e87e9851",
      "primary_moa": "HER2 pathway inhibition with trastuzumab or cetuximab, and immunotherapy with PD-1/PD-L1 inhibitors."
    }
  },
  "NCT06751329": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:07.174232Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:07.174241Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ae844bece4678ef30c7575a61d9eff4f",
      "primary_moa": "Not specified"
    }
  },
  "NCT06735326": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.4,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:10.890958Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:10.890973Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "52020f864a242ed18912643f4494d8b6",
      "primary_moa": "DNA Damage Repair (PARP inhibitors) and Angiogenesis (VEGF inhibitors)"
    }
  },
  "NCT05619913": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:14.820544Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:14.820560Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6a23030e111c5ecfd3415f9765f9e2c5",
      "primary_moa": "Immunotherapy (PD-1, PD-L1, CTLA-4 inhibitors)"
    }
  },
  "NCT05746897": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:19.670975Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:19.670991Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3bc817cd2977c5dbc2deddf732f55397",
      "primary_moa": "Immunotherapy (PD-1, PD-L1, CTLA-4 inhibitors)"
    }
  },
  "NCT05824975": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:23.904338Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:23.904365Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b27277b1d8b269d0185582d6f54bd72b",
      "primary_moa": "Immunotherapy and Angiogenesis"
    }
  },
  "NCT06253520": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.6,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:28.753082Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:28.753106Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "354f148dd257efe812f77c1e85704528",
      "primary_moa": "Immunotherapy targeting KRAS mutations with a vaccine"
    }
  },
  "NCT05579366": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:33.550863Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:33.550876Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8a0331e948528b99d665e887b16227b2",
      "primary_moa": "Immunotherapy and Angiogenesis"
    }
  },
  "NCT05740956": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:37.984134Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:37.984141Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f6bc30a29f81674e1070cd7af74b0875",
      "primary_moa": "PARP1 inhibition for DNA Damage Repair (DDR) in HRR gene mutant or HRD positive advanced solid tumors"
    }
  },
  "NCT06128551": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 1.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:42.178598Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:42.178617Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "edf0241d2817830b3a025d923dd2ce80",
      "primary_moa": "RMC-6291 and RMC-6236 combination therapy targets the KRAS G12C mutation, a key driver in solid tumors, likely through the MAPK pathway."
    }
  },
  "NCT04789694": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:46.356616Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:46.356632Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "679586fce61cf0212793becd347ab785",
      "primary_moa": "Multimodal prehabilitation focusing on physical, psychological, and nutritional support."
    }
  },
  "NCT05080556": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:51.468584Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:51.468601Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "63e5fb46b4403a3fcba537092fe954bf",
      "primary_moa": "The primary mechanism of action is likely related to the modulation of the PI3K/AKT pathway, as the trial focuses on adjusting the carboplatin dose based on changes in the serum biomarker CA125, which is a proxy for tumor burden and response to treatment."
    }
  },
  "NCT05638594": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.2,
      "vegf": 0.0,
      "her2": 0.8,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:55.782636Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:55.782651Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1905a9de3a545cb244abc75e12419bba",
      "primary_moa": "Pyrotinib, Trastuzumab, and Pertuzumab target the HER2 pathway, while Dalpiciclib and Letrozole may influence the PI3K/AKT pathway. This trial focuses on the neoadjuvant treatment of HR +/HER2 + breast cancer."
    }
  },
  "NCT04938583": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 1.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:58:59.777589Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:58:59.777619Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "41f95859aa83b9f2d36b926045758be5",
      "primary_moa": "This trial combines a VEGF inhibitor (bevacizumab) with a targeted therapy (oregovomab) and chemotherapy (paclitaxel, carboplatin) to inhibit angiogenesis and potentially enhance the efficacy of chemotherapy in BRCA wild-type, platinum-sensitive recurrent ovarian cancer."
    }
  },
  "NCT06915025": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:03.935310Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:03.935325Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "edd1c6c8ce86f39e6eb7fe4a18e54e64",
      "primary_moa": "This trial involves a combination of IMNN-001, a plasmid-based IL-12 formulation, with standard chemotherapy and PARP inhibitors. The primary mechanism of action is likely related to DNA Damage Repair (DDR) inhibition, as PARP inhibitors are commonly used in combination with chemotherapy to enhance DNA damage and increase cellular sensitivity to chemotherapy."
    }
  },
  "NCT06341907": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:08.872932Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:08.872942Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "964b669db7a5811753ab74b81dff619b",
      "primary_moa": "Immunotherapy (neoantigen polypeptide vaccine)"
    }
  },
  "NCT05887609": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:12.743236Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:12.743246Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "567bed82307409576064689c237d9e07",
      "primary_moa": "DNA Damage Repair (DDR) and Immunotherapy (IO) combination"
    }
  },
  "NCT05735080": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:16.384874Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:16.384881Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c5dc3bf667a2338c6516512064e4a18a",
      "primary_moa": "CDK2 inhibition"
    }
  },
  "NCT05827523": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:20.214968Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:20.214984Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cf7c5333345f1f939f5ca1e84e196f9f",
      "primary_moa": "Cisplatin is a DNA-damaging agent, but the trial does not provide specific information about its primary mechanism of action beyond its role in cytoreductive surgery."
    }
  },
  "NCT04104776": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:24.670781Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:24.670790Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1b1df9eae15bf58de1744a6987ca257e",
      "primary_moa": "DNA Damage Repair (PARP, ATR, ATM, CHK1/2, WEE1 inhibitors)"
    }
  },
  "NCT06334432": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.2,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:28.749507Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:28.749514Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "df60c02889a65ac3cb1e1f5d73aab5b2",
      "primary_moa": "NUV-1511 is a novel targeted therapy that primarily acts through the DNA Damage Repair (DDR) pathway, with potential involvement in the PI3K/AKT pathway."
    }
  },
  "NCT07069335": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:32.571774Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:32.571792Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dc42a4e087f91d2bba12f98da39ef19b",
      "primary_moa": "DNA Damage Repair (PARP, ATR, ATM, CHK1/2, WEE1 inhibitors)"
    }
  },
  "NCT04519151": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:36.772525Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:36.772545Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b1c93feaef09f5dde2039766247d3a46",
      "primary_moa": "Immunotherapy (PD-1, PD-L1 inhibitors) in combination with VEGF inhibitor"
    }
  },
  "NCT06840002": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:38.020379Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:38.020384Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2bfc54a38112804893246f5c9436582b",
      "primary_moa": "Angiogenesis and Immunotherapy"
    }
  },
  "NCT06513962": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:41.990400Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:41.990408Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "37bdeda377834b2f0cadc97c830b9e86",
      "primary_moa": "Triptorelin's primary mechanism of action is hormone blockade, specifically targeting the hormones that stimulate the ovaries to produce estrogen and progesterone."
    }
  },
  "NCT06225284": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:45.760884Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:45.760897Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cdb7cfd9392ad5f214ebefd86480e0ea",
      "primary_moa": "Immunotherapy (T cell response)"
    }
  },
  "NCT05445778": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 1.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:49.672906Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:49.672915Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "32dacdf07f95b591ec35cbeae53d3206",
      "primary_moa": "Angiogenesis inhibition with Bevacizumab"
    }
  },
  "NCT05187338": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.9,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:53.399411Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:53.399424Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6f8919c3a5a5604bbdea322fdec9415d",
      "primary_moa": "Immunotherapy targeting CTLA-4, PD-1, and PD-L1 pathways"
    }
  },
  "NCT04840589": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-08T23:59:57.257826Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-08T23:59:57.257836Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9e2e5866bd574b8582e9559acf78774a",
      "primary_moa": "Immunotherapy (PD-1, PD-L1, CTLA-4 inhibitors)"
    }
  },
  "NCT07059845": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:00.999319Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:00.999354Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "594d0c111d9eae3e51003a678b279954",
      "primary_moa": "Angiogenesis and Immunotherapy"
    }
  },
  "NCT05538091": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:05.310528Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:05.310534Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "beaf063e1769bab2a6e643d58521c8a7",
      "primary_moa": "Immunotherapy (PD-1, PD-L1, CTLA-4 inhibitors) and DNA Damage Repair (PARP, ATR, ATM, CHK1/2, WEE1 inhibitors)"
    }
  },
  "NCT05872204": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:09.315440Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:09.315453Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e3ca331a569558a104409ba23452926d",
      "primary_moa": "Abemaciclib and Letrozole target multiple pathways in estrogen receptor-positive rare ovarian cancer."
    }
  },
  "NCT06890858": {
    "moa_vector": {
      "ddr": 0.5,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:14.046466Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:14.046484Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ef280b6cd0881185338bdc2f0363716a",
      "primary_moa": "Fasudil Hydrochloride may influence DNA Damage Repair and Immunotherapy pathways in cancer treatment."
    }
  },
  "NCT05985655": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:17.737193Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:17.737210Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bcb9cb2134606b784b1db4b2e4ccb1f3",
      "primary_moa": "No clear mechanism of action identified."
    }
  },
  "NCT06677190": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:22.194058Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:22.194074Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c2a12ad3ea1f021320841807c0a775cf",
      "primary_moa": "Belzutifan is a HIF-2a inhibitor, which primarily targets hypoxia-induced pathways. It does not directly target DNA damage repair, MAPK, PI3K/AKT, angiogenesis, HER2, or drug efflux pathways."
    }
  },
  "NCT02639650": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:26.108438Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:26.108474Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1925a75e683e33db6b9aba8acf70f123",
      "primary_moa": "Chemotherapy combination targeting multiple pathways"
    }
  },
  "NCT04236479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:30.024897Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:30.024914Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "95dd16f680712314014de37d3b1209aa",
      "primary_moa": "Mesenchymal stromal cells (MSCs) have shown potential in promoting cardiac repair and regeneration through various mechanisms, including angiogenesis, anti-inflammatory effects, and direct cell differentiation."
    }
  },
  "NCT04180579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:33.960719Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:33.960727Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "074a8c56cc7c5e053e2b4bd22afa7ca6",
      "primary_moa": "The trial suggests a focus on preventing hair loss, which is a common side effect of chemotherapy. The Paxman Scalp Cooling System is designed to lower the temperature of the scalp, potentially reducing the damage to hair follicles and thus preventing hair loss."
    }
  },
  "NCT06412679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:38.154070Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:38.154080Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "99d15cfce8411558c2445ab24e7be053",
      "primary_moa": "Psychological Resilience and Mental Health Support"
    }
  },
  "NCT04497779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:42.077418Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:42.077432Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "81faa5b7d6589d5e6de97ce231734eef",
      "primary_moa": "The trial focuses on the use of COVID-19 convalescent plasma (CCP) as a potential therapeutic or prophylactic approach, which suggests an immune-based mechanism of action."
    }
  },
  "NCT03408379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:45.813958Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:45.813974Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "29f157c689fc6b5d81705056df087735",
      "primary_moa": "Platelet activation may contribute to aneurysm rupture through its role in vascular inflammation and thrombosis."
    }
  },
  "NCT05203679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:49.862651Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:49.862658Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "261c6c50a3aba191645801b9b070f33a",
      "primary_moa": "The primary mechanism of action is the restoration of factor IX levels through gene therapy, which is not directly related to the mechanisms listed."
    }
  },
  "NCT04670679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:53.935715Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:53.935729Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "48718d4298465752ec9d41885bf6a4e2",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT03906279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.5,
      "her2": 0.0,
      "io": 0.3,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:00:58.035428Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:00:58.035442Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "74b6e9873b9ed7b1f75fcf79d4d971ac",
      "primary_moa": "The trial focuses on choroidal thickness changes due to physiological and refractive changes, which may involve multiple mechanisms."
    }
  },
  "NCT06602479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:02.271966Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:02.271990Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8e38f2eddcd3f44f944d30256ad51108",
      "primary_moa": "The trial focuses on the efficacy of MEDI0618 in reducing the frequency and severity of episodic migraines, suggesting a potential involvement in pain modulation or neurovascular mechanisms."
    }
  },
  "NCT06411379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.7,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:06.203180Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:06.203190Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "be0e8bce7c7b6d9b4f7f8d46f5a25eb5",
      "primary_moa": "Immunomodulation and anti-inflammatory effects"
    }
  },
  "NCT06957379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.8,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:10.919269Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:10.919289Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dab1dd401455fa7d684e5d5464b54623",
      "primary_moa": "This trial focuses on the combination of Sirolimus for Injection (Albumin-bound) with endocrine therapy (Letrozole, Anastrozole, Exemestane, Fulvestrant) for HR+/HER2- advanced/metastatic breast cancer patients who have failed standard therapy. The primary mechanism of action is likely related to the PI3K/AKT pathway inhibition, as Sirolimus is an mTOR inhibitor, and endocrine therapy targets the estrogen receptor, which is a key component of the PI3K/AKT/mTOR pathway."
    }
  },
  "NCT06157879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:14.952848Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:14.952856Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "796db945562ce5588d7c3e27a95c05fd",
      "primary_moa": "The study focuses on electrical properties of breast tissue and their correlation with breast density, suggesting a potential role in cancer detection or diagnosis, possibly through the modulation of electrical properties."
    }
  },
  "NCT03436979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:19.347505Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:19.347512Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a29984ce0f368f7a4de01e777b689c96",
      "primary_moa": "The NeuGuide\u2122 System is designed to support and stabilize the uterus, likely through mechanical support and tissue engineering, rather than a specific molecular mechanism."
    }
  },
  "NCT04626479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:24.048749Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:24.048764Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3cc854a420f6370a33c25b4490772028",
      "primary_moa": "Angiogenesis and Immunotherapy"
    }
  },
  "NCT03274479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:27.952036Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:27.952044Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e37daffd62c00523820b1dbf4c3a50d2",
      "primary_moa": "No clear mechanism identified"
    }
  },
  "NCT05076279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:31.914943Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:31.914949Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "87e56ac1b59246626b8b25e570a1e49b",
      "primary_moa": "Laparoscopic surgery for advanced gastric cancer likely involves multiple mechanisms, including improved surgical precision and reduced postoperative pain, which can enhance patient recovery and potentially impact cancer cell behavior."
    }
  },
  "NCT03053479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:35.693797Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:35.693811Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f8377e9745ebba3f4c8aa63819e8511f",
      "primary_moa": "The trial focuses on surgical interventions for pelvic organ prolapse (POP), which suggests a focus on the surgical repair process itself rather than a specific molecular mechanism."
    }
  },
  "NCT04865679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:39.679525Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:39.679557Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b71a3827a4c878fa5f48c5b8f30c8651",
      "primary_moa": "The study focuses on the use of a nerve cap to protect and preserve terminated nerve endings, suggesting a mechanism related to nerve regeneration and protection."
    }
  },
  "NCT04430179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:43.930855Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:43.930874Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7ec7aa4f89c39abc2bc50e21d6d99172",
      "primary_moa": "Dupilumab is a biologic that targets the IL-4 and IL-13 cytokines, which are key drivers of eosinophilic inflammation. It is used to treat severe eosinophilic chronic sinusitis without nasal polyposis, a condition characterized by excessive mucus production and inflammation in the sinuses."
    }
  },
  "NCT04159779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:48.021457Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:48.021477Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cc8e5f62b55ae42cccfbc4e24f155c44",
      "primary_moa": "Venetoclax is a selective inhibitor of the B-cell lymphoma 2 (Bcl-2) family of proteins, which are involved in apoptosis. This mechanism is the primary focus of the trial, as it is a targeted therapy for CLL patients."
    }
  },
  "NCT05987579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:52.011855Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:52.011862Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3fde33cf8f1d2ce7e9a3f0b10b116854",
      "primary_moa": "Surgery directly targets the tumor, potentially affecting multiple pathways."
    }
  },
  "NCT06993779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:01:56.292329Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:01:56.292334Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7f2c75ce7a97f5e4880eb900d8952a9b",
      "primary_moa": "Prognostication prediction using deep learning system based on radiomics and whole slide images"
    }
  },
  "NCT04770779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:00.082349Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:00.082391Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2e50191206d35f021767ea8fa747bb02",
      "primary_moa": "Mitapivat is a HFE inhibitor that reduces iron overload in patients with alpha- or beta-thalassemia, which is a primary mechanism of action."
    }
  },
  "NCT05376579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:03.956097Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:03.956106Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1fa7fd784fdf8c47ca7a36b366cc020a",
      "primary_moa": "Immunomodulatory effects"
    }
  },
  "NCT04535479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:07.688503Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:07.688520Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ed6d11d6174d0a0ebf3ebeb1e5c21b55",
      "primary_moa": "Neuromodulation and Muscle Relaxation"
    }
  },
  "NCT03160079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.5,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.7,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:12.029195Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:12.029216Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ce046ac35505a6ce2def15f2c1c44c4c",
      "primary_moa": "Immunotherapy (PD-1, PD-L1, CTLA-4 inhibitors) and targeted therapy (PI3K/AKT pathway inhibitors)"
    }
  },
  "NCT04193579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:16.747958Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:16.747971Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "654953bb09fb7a800642c7c9df58a08c",
      "primary_moa": "The primary mechanism of action is likely related to the auditory and language development stimulation provided by the mother's voice, which may enhance neural and cognitive outcomes in premature infants."
    }
  },
  "NCT05617079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:21.830456Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:21.830478Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "67a6615ec09507d38fbb84b4f914e16f",
      "primary_moa": "Nebulizer therapy is primarily used for the inhalation of drugs to manage respiratory failure and disease, focusing on symptom relief and supportive care rather than a specific molecular mechanism."
    }
  },
  "NCT01483079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:25.983479Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:25.983499Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "fba2ebf85efd6ee3ee19a7699db3cca9",
      "primary_moa": "Human milk feeding promotes growth and neurodevelopment in premature infants, potentially through multiple mechanisms including nutrient provision, immune support, and protection against infections."
    }
  },
  "NCT03435679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:29.686061Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:29.686076Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "545dc6d402bdcb7250451200d5041f4b",
      "primary_moa": "The trial suggests a focus on surgical intervention rather than a specific molecular mechanism."
    }
  },
  "NCT05393479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:33.385589Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:33.385602Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "76a239c8a76f8a861266971ce791f50c",
      "primary_moa": "Psychological intervention for perinatal depression"
    }
  },
  "NCT03418779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:37.280948Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:37.280964Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "13e84850afde9d3c0469bd90f9cd7095",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT06750679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:41.301304Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:41.301320Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "829f0040c1e6a02610fcf69bdeec212c",
      "primary_moa": "Manual lymphatic drainage (MLD) is a form of physical therapy that helps stimulate the lymphatic system, which is crucial in managing lymphedema. This trial focuses on the adjunctive use of MLD to compression therapy, suggesting a primary mechanism of action related to lymphatic drainage and fluid management."
    }
  },
  "NCT04569773": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:45.385305Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:45.385323Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8ff571ed914a206d55bbebf864978e77",
      "primary_moa": "The trial focuses on decision-making and reproductive concerns, suggesting an impact on the psychological aspects of cancer treatment, potentially influencing the patient's perception of risk and treatment options."
    }
  },
  "NCT02502266": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.2,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:49.465093Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:49.465111Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f91706e599168ed974399d4cadcd9a18",
      "primary_moa": "This trial primarily focuses on the combination of targeted therapies, Cediranib and Olaparib, to inhibit DNA Damage Repair (DDR) pathways, potentially enhancing the efficacy of chemotherapy in platinum-resistant ovarian cancer."
    }
  },
  "NCT02101775": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.2,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:53.562214Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:53.562232Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ad71eb07052a5b747e3209f237e079f4",
      "primary_moa": "Gemcitabine hydrochloride is a DNA-damaging agent, and the trial includes a WEE1 inhibitor, which targets the DNA damage response pathway. This combination may enhance DNA damage and cell cycle arrest, leading to cancer cell death."
    }
  },
  "NCT04047251": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.2,
      "pi3k": 0.1,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:57.347837Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:57.347853Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d1fca9d22beae841c2b2a6bf5f22203b",
      "primary_moa": "Topotecan is a topoisomerase I inhibitor, primarily targeting DNA damage repair and cell cycle progression."
    }
  },
  "NCT02873962": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:02:58.675336Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:02:58.675342Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b25afead0c5982238a067241747888b7",
      "primary_moa": "The primary mechanism of action involves targeting angiogenesis (VEGF) and immunotherapy (PD-1/PD-L1 inhibitors)."
    }
  },
  "NCT02896452": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:03.036596Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:03.036659Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ee36467e507efa935544488c7f0e628b",
      "primary_moa": "The trial suggests a potential mechanism involving increased homocysteine concentrations and intracranial hypertension, which are associated with PCOS and may contribute to ophthalmologic issues in astronauts."
    }
  },
  "NCT03965481": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:07.381182Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:07.381197Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b57d5dd9d070300acebddf8ff758b7ff",
      "primary_moa": "This trial focuses on the imaging capabilities of PET/MR versus CECT scans in ovarian cancer, suggesting a primary mechanism related to imaging and diagnostic accuracy."
    }
  },
  "NCT06940921": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:11.284648Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:11.284662Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6d4c7d4b32241ce08d0f21f71e0389aa",
      "primary_moa": "The primary mechanism of action involves the combination of low-dose radiation and stereotactic body radiation therapy (SBRT) with Cadonilimab to target peritoneal lesions in patients with advanced cancers. This approach aims to control tumor growth and potentially enhance the immune response."
    }
  },
  "NCT03860272": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:15.268130Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:15.268150Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0a6e7c0b6553cc8db74b0fc0bc84a4fa",
      "primary_moa": "Immunotherapy (CTLA-4 and PD-1 inhibitors)"
    }
  },
  "NCT05116189": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:19.258936Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:19.258947Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c6c6e19440343f5a80c7a59475382828",
      "primary_moa": "The primary mechanism of action is angiogenesis inhibition (VEGF) combined with immunotherapy (PD-1/PD-L1 inhibitors)."
    }
  },
  "NCT05617755": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:22.944452Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:22.944458Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1618aec520369e8d03553004df255050",
      "primary_moa": "No clear mechanism identified"
    }
  },
  "NCT04024878": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:27.032350Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:27.032363Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ae679ed2cdb42eaf6a771963930dc075",
      "primary_moa": "Immunotherapy (PD-1, PD-L1, CTLA-4 inhibitors) and Cancer Vaccine"
    }
  },
  "NCT05051696": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:30.932610Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:30.932616Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "92a3e27d2a2e09609e532d32b3211757",
      "primary_moa": "Oncolytic Virotherapy"
    }
  },
  "NCT01366144": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.4,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:34.747995Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:34.748007Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c56d9f51a357cab43b4d82b9fa8b9850",
      "primary_moa": "Veliparib targets DNA Damage Repair pathways, while paclitaxel and carboplatin are chemotherapeutic agents that work through different mechanisms to inhibit tumor cell growth."
    }
  },
  "NCT04065009": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:38.616070Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:38.616081Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3dcb8a1d325c406effb21da938986147",
      "primary_moa": "Cytoreductive surgery and adjuvant chemotherapy targeting tumor dissemination in the peritoneal cavity"
    }
  },
  "NCT06784479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:42.510196Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:42.510215Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "75e5d610b8e6b3971b124c409bd50f0d",
      "primary_moa": "Sedation and Sleep Regulation"
    }
  },
  "NCT06681779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:46.605940Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:46.605959Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c1768e6e7f430c1b4327f1ada416a12e",
      "primary_moa": "Transcutaneous electrical stimulation as a noxious stimulus for the Glasgow Coma Scale"
    }
  },
  "NCT05858879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:50.850530Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:50.850548Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cd1500bb84292e969078fd63f9fbae56",
      "primary_moa": "The primary mechanism of action is likely related to the impact of patient and clinician awareness on therapeutic decision-making, potentially influencing lipid-lowering therapy initiation."
    }
  },
  "NCT06221579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:54.673167Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:54.673182Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f2947c9074777f2bb8af347d13b4971b",
      "primary_moa": "Cognitive enrichment and physical activity may improve cognitive health in older adults with mild cognitive impairment (MCI)."
    }
  },
  "NCT06419179": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:03:58.587822Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:03:58.587830Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5a15109c97daf63d6c5ff6d69a7b789d",
      "primary_moa": "This trial combines DNA damage repair inhibition (DDR) with immunotherapy, suggesting a primary mechanism of enhancing the immune response against cancer cells with DDR defects."
    }
  },
  "NCT04081779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:02.454304Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:02.454323Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7649ded8c6c51dd63918735423bec241",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT05523479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:06.877741Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:06.877752Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ce925b6077582a273e4df012b5c0e7ec",
      "primary_moa": "Interprofessional education and protocol-directed care for post-extubation care in acute respiratory failure"
    }
  },
  "NCT03820479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:12.406426Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:12.406440Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "201a0708bd03aa06ab4633a27c4b78ef",
      "primary_moa": "The study focuses on the impact of Apfel-score based PONV care and prophylaxis on post-operative recovery in high-risk female patients undergoing laparoscopic abdominal surgery. This suggests a focus on managing and preventing PONV, which is a form of post-operative nausea and vomiting. This mechanism is likely related to the Apfel score, which is a tool used to assess the risk of PONV."
    }
  },
  "NCT06706479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:16.505312Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:16.505329Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "946b35a8530182e1e592ff303d2d8dd9",
      "primary_moa": "The primary mechanism of action appears to be related to neuromodulation and potentially pain relief, as the trial focuses on the effects of transcranial direct current stimulation on chronic low back pain and balance in older adults."
    }
  },
  "NCT06862479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:20.704311Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:20.704327Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "67e23bfa702775866ee4b5fa0d85d31c",
      "primary_moa": "The primary mechanism of action involves the management of adverse events following bariatric surgery, which can be categorized as a form of postoperative care and management of complications."
    }
  },
  "NCT04421963": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:24.590876Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:24.590883Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d8d36d216aa909fef98e3a006766197d",
      "primary_moa": "Continued treatment with olaparib for patients who have participated in a parent study and are continuing to derive clinical benefit."
    }
  },
  "NCT01402479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:28.482648Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:28.482659Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5c2254f5fa190446f3b2db62e3be928d",
      "primary_moa": "Migraine prophylaxis via renin-angiotensin system modulation"
    }
  },
  "NCT00812279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:32.476625Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:32.476635Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c9274e1925f4586a49938ab992636705",
      "primary_moa": "The trial focuses on the exposure to smoke constituents and the comparison of biomarkers in smokers switching to a distillation-based smoking article (SMAR cigarette) versus conventional cigarettes (CC). This suggests a primary mechanism related to the exposure and potential differences in the body's response to these smoke constituents."
    }
  },
  "NCT03058679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:36.274858Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:36.274922Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1671d2e78ad462ac1c0529c29f195fc1",
      "primary_moa": "Dietary intervention for Crohn's disease, focusing on reducing inflammation and symptoms through specific carbohydrate and Mediterranean diets."
    }
  },
  "NCT02385279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:40.422617Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:40.422631Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a5610e08e090bfbdec72b100bfde028c",
      "primary_moa": "The trial compares stents (MISTENT SES and XIENCE EES) for the treatment of coronary stenosis, focusing on clinical outcomes over 3 years. This suggests a focus on vascular biology and potentially angiogenesis, as stents are used to improve blood flow in the coronary arteries."
    }
  },
  "NCT04128579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:44.373038Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:44.373053Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "49249e9aa0e195150519b146023fea06",
      "primary_moa": "Itolizumab is an anti-CD3 antibody that modulates T-cell activation and function, suggesting an Immunotherapy (IO) mechanism."
    }
  },
  "NCT05646979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:48.375953Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:48.375968Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d5da0c8d324646dffea5b1b941865a01",
      "primary_moa": "Emotional regulation and stress reduction through EFT may influence surgical outcomes and patient comfort during cesarean section."
    }
  },
  "NCT01216579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:52.240837Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:52.240850Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d52bc6ccb6cdcdaa28264211c86b40f5",
      "primary_moa": "The trial involves a comparison of asthma medication titration against a mannitol challenge, suggesting a focus on airway inflammation and potential modulation of the immune response."
    }
  },
  "NCT01584479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:04:56.133414Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:04:56.133438Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "51559e63eb673ddfdcca9fc01219cc48",
      "primary_moa": "The study focuses on the prevention of periodontitis through risk stratification and increased preventive services, suggesting a focus on disease prevention and management rather than a specific molecular mechanism."
    }
  },
  "NCT03235479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:00.124185Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:00.124193Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7879b7ca498e46bd052f9da80d161a46",
      "primary_moa": "Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonism"
    }
  },
  "NCT02898779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.8
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:04.122015Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:04.122067Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "43ca2b1b38ffc57e1ca4de433436e9fd",
      "primary_moa": "The trial focuses on the metabolism and pharmacokinetics of primaquine enantiomers, suggesting a primary mechanism related to drug metabolism and transport."
    }
  },
  "NCT02840279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:07.969974Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:07.969988Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5c825fad551f96ae2960c2641f853fbc",
      "primary_moa": "Cognitive enhancement in elderly subjects"
    }
  },
  "NCT03789279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:11.794546Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:11.794560Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "90d169d9e6bce1e8dcfba0be3bb947dd",
      "primary_moa": "The study suggests a potential mechanism involving nerve injury and radial artery occlusion, which may lead to hand dysfunction. This could be related to the disruption of blood flow and nerve function during the angiography procedure."
    }
  },
  "NCT00739479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:15.895672Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:15.895684Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "97de31de9b3bc0630ed2e2f3b96680a8",
      "primary_moa": "The primary mechanism of action appears to be related to the modulation of protein metabolism and its impact on weight loss."
    }
  },
  "NCT04591379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:19.873288Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:19.873294Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5ec3e6ed1db49891e7484fcb9e570585",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT01294579": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:24.322397Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:24.322425Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "85db7f2a76d7b151c43820d8d5a3a37f",
      "primary_moa": "The primary mechanism of action involves the combination of Ofatumumab and Bendamustine, which are both anti-cancer agents. Ofatumumab is a fully human monoclonal antibody that targets CD20, a protein found on the surface of B cells. Bendamustine is a nitrogen mustard analog that induces DNA damage and apoptosis. This combination therapy is designed to target and eliminate B-NHL cells."
    }
  },
  "NCT04614779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:28.283752Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:28.283760Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2e8498447cbc4aa4544fa29ddad073ee",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT02351479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:32.280850Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:32.280864Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "236fc1257018e564e175380798ba8dd4",
      "primary_moa": "Hula as a form of physical activity may have a positive impact on the biological and psychosocial well-being of female cancer survivors, potentially affecting multiple pathways."
    }
  },
  "NCT01757379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:36.288462Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:36.288502Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a13816b24f8bdcb4845aac93c395c8fd",
      "primary_moa": "The study evaluates the bioavailability of short-chain fatty acids (SCFAs) and their production from inulin, which can be linked to their role in gut microbiome metabolism and potential effects on host physiology."
    }
  },
  "NCT04665479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:40.595563Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:40.595574Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f9fb7693ab58350e073fdf734ee65067",
      "primary_moa": "The trial focuses on a web-based storytelling intervention for children with serious advanced illnesses, aiming to address the lack of home-based end-of-life and palliative care for rural populations. This approach may indirectly support the development of coping mechanisms and emotional well-being, potentially influencing the 'efflux' mechanism by providing a means of emotional expression and support."
    }
  },
  "NCT00575679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:44.362161Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:44.362176Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "47152c5efd524cc2755f4954db7a9ab3",
      "primary_moa": "Brief motivational interview may influence behavior change by encouraging individuals to reflect on the consequences of their actions and fostering a sense of personal responsibility."
    }
  },
  "NCT01355679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:48.070632Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:48.070642Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "89cf841527c81b399b2a19d9f230ba1d",
      "primary_moa": "Molecular profiling to guide cancer treatment"
    }
  },
  "NCT03743779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.5,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:52.061910Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:52.061922Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cd3562f3a0e4f55e572383fd039caaa0",
      "primary_moa": "The study focuses on the survey of a past program, suggesting an observational or retrospective analysis rather than an intervention-driven mechanism of action."
    }
  },
  "NCT00372879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:55.870756Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:55.870765Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8f542d54ed05be95c9649a51dd02ff71",
      "primary_moa": "Vitamin E is an antioxidant, and its primary mechanism of action in this trial is likely related to its anti-inflammatory and neuroprotective effects, which may help reduce muscular cramps in ALS patients."
    }
  },
  "NCT03284879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:05:59.597267Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:05:59.597281Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5984da39c67766f9c30e8d665a858b06",
      "primary_moa": "Immunomodulation"
    }
  },
  "NCT05357079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:03.427370Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:03.427379Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9e38d955986277c6be6e52befd79753c",
      "primary_moa": "The primary mechanism of action is likely related to the anti-hemorrhagic effect of tranexamic acid, which may reduce blood loss and stabilize hemoglobin levels in patients with acetabular fractures."
    }
  },
  "NCT04801979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:07.236384Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:07.236409Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "89b8c3d82882f65b86f0c14996d2ea03",
      "primary_moa": "Cardiorespiratory Fitness and Exercise Capacity"
    }
  },
  "NCT01312779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:10.994197Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:10.994205Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3b45d9aed79c967056717d1bd62d060d",
      "primary_moa": "Mitral valve replacement"
    }
  },
  "NCT03287479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:15.151970Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:15.151995Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "361ede8253915b86849444abb18aa4a3",
      "primary_moa": "The primary mechanism of action is likely related to the standardization of the vitrification process and the use of a closed system, which may enhance the safety and efficiency of embryo cryopreservation."
    }
  },
  "NCT02079779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:16.135751Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:16.135770Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "458e7ebe293b9d6aeeb7314fe62c4bae",
      "primary_moa": "Robotic-assisted therapy likely enhances motor recovery through repetitive, precise, and adaptive exercise, providing real-time feedback for improved movement quality."
    }
  },
  "NCT04617379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:20.159560Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:20.159568Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dd8dc85453dfa84a72bafeb8235d9a4b",
      "primary_moa": "Stretching may reduce musculoskeletal pain by improving flexibility and muscle function, potentially through the activation of mechanosensitive ion channels and the release of anti-inflammatory factors."
    }
  },
  "NCT01713179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:24.188910Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:24.188927Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dff7208a97bc1ed7808cfdbf1db044db",
      "primary_moa": "Ambroxol's mechanism of action primarily involves the degradation of mucin polymers and other components in airway secretions, which is a characteristic feature of mucolytic agents."
    }
  },
  "NCT06355479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:28.109854Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:28.109869Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "96811b896bbc38622557f8e8f4dae44a",
      "primary_moa": "OsrHSA is a human serum albumin (HSA) replacement therapy, likely acting through the albumin's role in maintaining oncotic pressure and nutrient transport, which may indirectly support overall liver function in patients with hypoalbuminemia and cirrhosis."
    }
  },
  "NCT00714779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:32.083774Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:32.083787Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2846b8ef8a8ea6f7d9f38182448a94c3",
      "primary_moa": "Neurotransmitter Regulation and Psychotherapy-Induced Neuroplasticity"
    }
  },
  "NCT02911779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:35.978903Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:35.978919Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "21e9d6b29c5f18e8b748e9ee5d38b54c",
      "primary_moa": "The trial suggests a focus on the angle of episiotomy lines during labor, which may influence the mechanism of action by affecting tissue trauma and healing."
    }
  },
  "NCT02922179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:39.823815Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:39.823822Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b87776be0ec50549a8e544c2684ae363",
      "primary_moa": "Insulin signaling and glucose metabolism"
    }
  },
  "NCT03564379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:43.519190Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:43.519206Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8c0bf509a8acc261de974ee063817c25",
      "primary_moa": "Pharmacokinetic study with potential indirect effects on cell signaling pathways"
    }
  },
  "NCT02859779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:47.345437Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:47.345452Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "053f93f9ab568d72913b167af29907ab",
      "primary_moa": "Therapeutic patient education (TPE) is a key mechanism of action for improving glycemic control in adolescents with type 1 diabetes."
    }
  },
  "NCT03031379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.3,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:51.130964Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:51.130981Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0e41960d052f51ef24f2b5782fc6f60b",
      "primary_moa": "Shortened preoperative fasts may influence the immune response and potentially affect the body's ability to heal and recover post-surgery."
    }
  },
  "NCT00170079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:55.275171Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:55.275183Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9291425d2945e519c2b3acc6a88d970d",
      "primary_moa": "The trial focuses on smoking cessation, which is a complex process involving multiple biological mechanisms. The primary mechanism of action is likely related to the regulation of the neurobiological pathways that drive nicotine addiction and withdrawal symptoms."
    }
  },
  "NCT05999279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:06:59.154812Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:06:59.154818Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6ca0cf661eb438c8a3c5c2b13c40b2c9",
      "primary_moa": "Digital pharmaceutical care does not directly target specific molecular pathways but rather focuses on providing remote pharmaceutical services and patient counseling."
    }
  },
  "NCT01247779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:03.297861Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:03.297891Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5d341eb5059ac1ff9409e073afd70696",
      "primary_moa": "This trial focuses on comparing surgical techniques (coelioscopy vs. robot-assisted coelioscopy) rather than targeting specific molecular pathways or mechanisms."
    }
  },
  "NCT01104779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:07.443936Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:07.443972Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3d34fd6671f8a01868fda71730d4a85d",
      "primary_moa": "Cariprazine is a dopamine receptor antagonist, primarily targeting D2 and D3 receptors. It may also have partial agonist activity at the D4 receptor. This mechanism of action is relevant to the treatment of schizophrenia, as it helps to manage symptoms such as delusions and hallucinations."
    }
  },
  "NCT05671679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:11.304215Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:11.304230Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e011dca1b398b6df702c36373263a65c",
      "primary_moa": "SNAQ app may improve glycaemic control by reducing the burden and error associated with carbohydrate counting, potentially through enhanced user engagement and accuracy in food analysis."
    }
  },
  "NCT05468879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:15.093653Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:15.093667Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "291c2b9f125c608087ea8d532abefd41",
      "primary_moa": "Bioequivalence study of Glimepiride and Amaryl, focusing on drug absorption and bioavailability."
    }
  },
  "NCT03412279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:18.983550Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:18.983557Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b2c1c1212297d37bcbca98458cf012c9",
      "primary_moa": "This trial focuses on the validation of patient self-reported measures in patients with chronic low back pain, indicating a potential emphasis on psychological and functional aspects of pain management rather than a specific molecular or cellular mechanism."
    }
  },
  "NCT03444779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:22.680167Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:22.680176Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0e35416e94ef8562b2e1dbba7fa6ced0",
      "primary_moa": "Tibial Tuberoplasty likely involves bone healing and fracture fixation mechanisms."
    }
  },
  "NCT03620279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:26.660503Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:26.660517Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f13bf09543c8c3a62f762021ba1031ef",
      "primary_moa": "The trial focuses on improving motor function and quality of life in children with hemiplegic cerebral palsy, suggesting a primary mechanism related to motor function and neurological recovery."
    }
  },
  "NCT03752879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:30.654013Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:30.654020Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bd9a8a2b656c459287b8850197344e08",
      "primary_moa": "Fundal pressure during the second stage of labor may cause mechanical trauma to the levator ani muscle, leading to avulsion injuries."
    }
  },
  "NCT02506179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:34.464015Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:34.464032Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "01855e6d02fe213b497c49e8d86a0892",
      "primary_moa": "Adalimumab is an anti-TNF-\u03b1 agent, which primarily modulates the immune response and reduces inflammation. It may also have indirect effects on psychological distress/depression symptoms through improved quality of life and disease management."
    }
  },
  "NCT03530579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:38.337148Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:38.337162Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "36d00e00d526605b49b97f4e3cbc99bb",
      "primary_moa": "Community Health Worker Program for Diabetes Prevention"
    }
  },
  "NCT00943579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:42.638475Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:42.638492Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7a383914464b26fce8bc1d2f55befd03",
      "primary_moa": "Kuvan (sapropterin) is a biopterin derivative that acts as a cofactor for the enzyme phenylalanine hydroxylase, which is essential for the metabolism of phenylalanine. It is primarily used to treat phenylketonuria (PKU) and has shown some promise in improving social interactions and communication in children with autism."
    }
  },
  "NCT02356679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:46.732767Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:46.732781Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1a2155797f0f571dc4d386d3580d1f73",
      "primary_moa": "The trial suggests a focus on the anti-inflammatory and protective effects of Eupasidin-s Tab. in gastritis patients, potentially targeting multiple pathways."
    }
  },
  "NCT00589979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:50.625273Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:50.625301Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "66f1ffb8ccbcee2ed4000b7c9fa2ef0e",
      "primary_moa": "Local analgesia via lidocaine"
    }
  },
  "NCT02214979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:54.726906Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:54.726914Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f37c8ca39a911d3fdfaad32538e00bab",
      "primary_moa": "Bioequivalence study of a fixed-dose combination of telmisartan and ramipril, suggesting a focus on the interaction and bioavailability of the two drugs."
    }
  },
  "NCT02309879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:07:58.721417Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:07:58.721424Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a4662f9bb920a7a90c0197c75a2a8891",
      "primary_moa": "The primary mechanism of action appears to be related to the modulation of pain pathways and the use of analgesic agents."
    }
  },
  "NCT02240979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:02.835950Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:02.835978Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7cc016cd14c3a198198916400d5fd20d",
      "primary_moa": "The study involves a non-invasive method to measure cardiac function using software loaded on an iPhone, which captures a pulse waveform. This method is compared to the gold standard cardiac MRI, suggesting a focus on cardiac imaging and function."
    }
  },
  "NCT03144479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:07.038235Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:07.038241Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ba43da822bf61b8f6092be220875f4fc",
      "primary_moa": "The primary mechanism of action involves the insertion of a central venous catheter wire guide into the bronchial arm of the right double-lumen tube, which is a technique that may indirectly affect the PI3K/AKT pathway by facilitating the delivery of drugs or substances that can modulate this pathway."
    }
  },
  "NCT05684679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:11.179562Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:11.179575Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "083b1e0e03a49b71a0d947bb2554b9dc",
      "primary_moa": "The primary mechanism of action involves enhancing respiratory function and reducing pulmonary complications in post-CABG patients through the use of incentive spirometry and diaphragmatic breathing exercises, which indirectly supports overall patient recovery and reduces the risk of complications."
    }
  },
  "NCT00313079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:15.058872Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:15.058886Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "694c58c85d12c43317bd3e0a81962cb1",
      "primary_moa": "Monoclonal Antibody (mAb) 216 targets B-lineage acute lymphoblastic leukemia cells, likely through direct cell killing and potentially enhancing the immune response."
    }
  },
  "NCT00021879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:18.836807Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:18.836825Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "06347b407d6ea7da121724f94afc5254",
      "primary_moa": "The trial focuses on the impact of visceral fat and obesity on cardiovascular disease and diabetes risk, suggesting a primary mechanism related to metabolic and cardiovascular effects."
    }
  },
  "NCT01965379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.5,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.3
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:23.080800Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:23.080821Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "011c6354830a8d9a35e3e37b654c2a1f",
      "primary_moa": "Dietary restriction of phosphorus additives to manage hyperphosphatemia in End-stage Renal Disease patients, potentially affecting multiple pathways."
    }
  },
  "NCT04409379": {
    "moa_vector": {
      "ddr": 0.6,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:26.978595Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:26.978610Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "7b75f256bee3494c1d4fb2342b504f4a",
      "primary_moa": "DNA Damage Repair and Immunotherapy"
    }
  },
  "NCT01507779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:30.871352Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:30.871368Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6c02f2d17ea8132e410818eb768dbb40",
      "primary_moa": "The primary mechanism of action is likely related to the immune response to the influenza virus, as the trial aims to assess the safety and immunogenicity of the vaccine."
    }
  },
  "NCT03331679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:34.665371Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:34.665398Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ca64163db75b92b73eeb07afd09e8bcb",
      "primary_moa": "Cardiorespiratory fitness improvement through high-intensity interval training (HIIT) in older adults"
    }
  },
  "NCT05936879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:39.264104Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:39.264118Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3648630f3c3f74dd1fec9da10954034e",
      "primary_moa": "The primary mechanism of action appears to be the activation of the exercise response, which is a well-known physiological adaptation to physical activity. The interventions of inspiratory muscle training and physical therapy, including ankle pumps and hand pumps isometrics, are designed to enhance muscle strength and endurance, which can improve exercise capacity and reduce dyspnea."
    }
  },
  "NCT04595279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:43.053278Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:43.053299Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ec8c4a05b87779e619dd23c40d2763c3",
      "primary_moa": "The trial suggests an indirect mechanism of action related to regulatory science and industry practices."
    }
  },
  "NCT03773679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:47.111437Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:47.111471Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8a80d61e457aa196fffc2d104600e752",
      "primary_moa": "The study suggests a potential mechanism involving the impact of daily exercise on bone mineral density and cortisol levels in preterm infants, which may indirectly influence bone health and metabolism."
    }
  },
  "NCT07018479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:51.142346Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:51.142363Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "29dd2c7d31f03e22537425ada4779e07",
      "primary_moa": "The study suggests a potential impact on hormone balance, which could influence PMS symptoms. While not directly targeting specific pathways, the focus on hormone balance may imply a broader regulatory effect on hormonal pathways."
    }
  },
  "NCT01392079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:54.804686Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:54.804698Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "27f6b4cb4f508ac7aa9d319e6b4cc3dc",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT03093779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:08:58.516162Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:08:58.516223Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2f0f2a545bd9db84857d8b12da16453f",
      "primary_moa": "Health literacy and information accessibility in the context of hearing loss"
    }
  },
  "NCT05652179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:02.303813Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:02.303832Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "64735a2b716f67ea6bf6bd1e6f53800a",
      "primary_moa": "Stellate ganglion block likely reduces inflammation and stress, promoting rapid recovery of kidney function after cardiac surgery."
    }
  },
  "NCT00271479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:06.307404Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:06.307421Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e00dc05c036a9a9a606b56bb22a719c8",
      "primary_moa": "The primary mechanism of action is not clear from the provided information."
    }
  },
  "NCT00736879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:10.190873Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:10.190879Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "fba99b2a67a386110fca31037a448d1a",
      "primary_moa": "Dapagliflozin is a SGLT2 inhibitor, which primarily works by reducing glucose reabsorption in the kidney, leading to increased glucose excretion and lower blood sugar levels."
    }
  },
  "NCT01938079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:14.082229Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:14.082247Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "05ec5d5a73975bdaaab6e400d5304feb",
      "primary_moa": "The trial involves the use of ECMO, which is a supportive care measure to assist patients with severe lung failure. It does not directly target specific molecular pathways but rather provides oxygenation and circulation support."
    }
  },
  "NCT00005079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.3,
      "efflux": 0.7
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:17.910770Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:17.910783Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f177197fb1892e70d4d2e45ce19baf14",
      "primary_moa": "The trial focuses on the timing of surgery during the menstrual cycle, suggesting a potential impact on the immune response and tissue healing, which may be related to immunotherapy and drug efflux mechanisms."
    }
  },
  "NCT02409979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:21.661745Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:21.661755Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8ceabe34ece38ba5c64c84598982b479",
      "primary_moa": "Carbon dioxide insufflation during colonoscopy leads to prolonged bowel distension and discomfort, likely due to gas retention and potential inflammation."
    }
  },
  "NCT00784979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:25.444315Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:25.444320Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "323e518073386ce55abe9fe1b47f157c",
      "primary_moa": "Immunomodulatory therapy to reduce PRA and improve transplant compatibility"
    }
  },
  "NCT01048879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.5
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:29.336901Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:29.336919Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6435102395bb345b23efe85c03e62d3a",
      "primary_moa": "The primary mechanism of action is likely related to the removal of oseltamivir from the bloodstream by CVVHD and ECMO, which may affect drug efficacy."
    }
  },
  "NCT03183479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:30.078035Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:30.078041Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e362b292f9cab109ffaad90b7e8d2cd8",
      "primary_moa": "Fibrinogen concentrate may reduce allogeneic blood transfusion by promoting hemostasis and coagulation."
    }
  },
  "NCT02408679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:33.951749Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:33.951773Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "880c2ee550fe008b445b76ee7486dbb6",
      "primary_moa": "The trial focuses on evaluating a predictive questionnaire for vitamin D insufficiency, which suggests a mechanism related to biomarker identification and diagnostic accuracy."
    }
  },
  "NCT03115879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:38.043389Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:38.043431Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c2070b6b3596b8d5671a7c3ac828d299",
      "primary_moa": "Manual therapy techniques, such as hip mobilization and manipulation simulation, are used to increase muscle activation and strength, potentially enhancing the effectiveness of traditional strengthening exercises in subjects with lower extremity pathology."
    }
  },
  "NCT03594279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:41.985641Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:41.985648Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "32487ff5fe41d69d72a743febf6dab1b",
      "primary_moa": "Community Mobilization and Incentives for Improved Sanitation and Hygiene"
    }
  },
  "NCT05626179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:45.827657Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:45.827675Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bdda414323e30f7d4bf30fcff2e8db69",
      "primary_moa": "The trial is evaluating the mass balance of a radiolabeled drug in healthy subjects, suggesting a focus on pharmacokinetics rather than a specific mechanism of action."
    }
  },
  "NCT04766879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:49.743297Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:49.743317Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "73a09f094609a573cf249e0df718afce",
      "primary_moa": "Spatial repellents reduce mosquito biting by making the environment inhospitable for mosquitoes, potentially decreasing malaria transmission."
    }
  },
  "NCT02773979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:53.712165Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:53.712179Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "25520de23baf9ffbc9447fa6ee6fffd7",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT01606579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:09:57.802897Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:09:57.802901Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1afd595d55ef63da8cd557bd89fb33c4",
      "primary_moa": "PRI-724 blocks the Wnt signaling pathway, which is essential for cancer cell growth and spread."
    }
  },
  "NCT03169179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:01.638435Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:01.638448Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6cd609dfc4d45c984aa98142aeb8e1c0",
      "primary_moa": "Physical Activity Promotion"
    }
  },
  "NCT05000879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:05.482885Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:05.482893Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "abacf77047f5f81023b4f0d1567b4243",
      "primary_moa": "Mindfulness-based intervention targeting mood and depression in pregnant women"
    }
  },
  "NCT05103579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:09.133726Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:09.133745Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cd0e92c7c431dc6afa9ca1009af434e5",
      "primary_moa": "Heart rate monitoring and stress assessment"
    }
  },
  "NCT03659279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:13.268294Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:13.268302Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "fc34406c829dbcd64f5a5237c8598b58",
      "primary_moa": "The trial focuses on enhancing executive functioning and time management skills in individuals with neurodevelopmental and mental disorders, without targeting specific molecular pathways or biological mechanisms."
    }
  },
  "NCT06306079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:17.167134Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:17.167208Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "80f9307366de6d281387ca100abe1799",
      "primary_moa": "Biomechanical modulation of gait to reduce knee loading and improve symptoms in knee osteoarthritis patients."
    }
  },
  "NCT04075279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:21.054911Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:21.054924Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "2af2cc9b241284be4bb416a14b5de345",
      "primary_moa": "The study focuses on cardiovascular mechanisms, particularly in the context of increased cardiovascular mortality in high-activity occupations. This suggests a primary mechanism related to cardiovascular health and risk factors."
    }
  },
  "NCT03782779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:24.741204Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:24.741222Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "62baf35241497648ee6d9359f1a26d1a",
      "primary_moa": "Respiratory System Function Improvement"
    }
  },
  "NCT03591679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:28.735453Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:28.735466Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "277e6bb2a7ad6e0195d8fc5f4f9020e3",
      "primary_moa": "Bilateral uterine artery ligation likely reduces postpartum hemorrhage by directly affecting uterine contractility and blood flow, rather than through the mechanisms of DNA damage repair, MAPK, PI3K/AKT, angiogenesis, HER2, or immunotherapy."
    }
  },
  "NCT02803879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:32.916579Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:32.916598Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f080c3400c1029c281e261b6a3da00bf",
      "primary_moa": "Cardiac Resynchronization Therapy (CRT) involves adjusting pacemaker settings to optimize ventricular synchronization, which is a form of cardiac resynchronization. This process is not directly related to DNA damage repair, MAPK, PI3K/AKT, VEGF, HER2, or immunotherapy pathways."
    }
  },
  "NCT04656379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:36.928983Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:36.929005Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d7a3d02ceac78b44ccab7f9db556e784",
      "primary_moa": "The trial suggests a focus on postoperative pain management as a potential modifiable risk factor for postoperative delirium in elderly patients. While not directly targeting DNA damage repair, PI3K/AKT pathway, or immunotherapy, the study highlights the importance of addressing postoperative pain to reduce the risk of delirium."
    }
  },
  "NCT00985179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:40.753756Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:40.753784Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4e268b587d1518d044e7de39b792b820",
      "primary_moa": "Psychological intervention and behavior modification"
    }
  },
  "NCT03152279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.2
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:44.547201Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:44.547223Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "3925cde2b8c3fa1d8f6c82bcffb3d777",
      "primary_moa": "Increased intestinal permeability due to compromised duodenal epithelial integrity, leading to immune response triggered by gluten peptides"
    }
  },
  "NCT00963079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:48.521490Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:48.521509Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "854deac88aeba215d3e328c2c3f64f69",
      "primary_moa": "This trial suggests a primary mechanism involving the impact of controlled ovarian stimulation on endometrial receptivity in high responders, potentially affecting embryo implantation."
    }
  },
  "NCT04119479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:52.494934Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:52.494953Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bdd75e60e155657796efdace5b19e338",
      "primary_moa": "Stroke recovery through rehabilitation"
    }
  },
  "NCT04722679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:10:56.259074Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:10:56.259097Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b20cf5848b33e1004f750a460a9955dc",
      "primary_moa": "Anticoagulation to prevent stroke and death in elderly patients with non-valvular atrial fibrillation"
    }
  },
  "NCT03236779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:00.139456Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:00.139476Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f81ec97671565be119b07ec4d461f975",
      "primary_moa": "Myofascial Release and Pain Modulation"
    }
  },
  "NCT04063579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:03.962201Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:03.962247Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "80fc5963927ee6d84df5b55eafda3171",
      "primary_moa": "Cardiac Magnetic Resonance Feature Tracking (CMR-FT) for diastolic function assessment in Heart Failure with Preserved Ejection Fraction"
    }
  },
  "NCT01385579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:08.056857Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:08.056880Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e0d73365c4056da3f6df384ad6f737e4",
      "primary_moa": "The primary mechanism of action is likely related to improving patient access and adherence to colorectal cancer screening, rather than directly targeting cancer cell pathways."
    }
  },
  "NCT03067779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:12.255004Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:12.255022Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "428ad51451fe01c80ca1506c409f472d",
      "primary_moa": "The primary mechanism of action is likely related to the use of mHealth tools for patient education and safety improvement in Chronic Kidney Disease (CKD)."
    }
  },
  "NCT02892279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:16.024116Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:16.024136Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "064510e9a3c48f060d220a0b0089bb65",
      "primary_moa": "Sympathetic nervous system activation"
    }
  },
  "NCT00055679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:19.898153Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:19.898159Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "979ef61e2a90e9d1516873ba2e6c5ca8",
      "primary_moa": "Combination chemotherapy targeting multiple cellular pathways"
    }
  },
  "NCT00636779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.5,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:23.721018Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:23.721090Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "26df5f037b1efed5909ce895ce5700c5",
      "primary_moa": "The trial focuses on integrative medicine, which often involves a combination of various therapeutic approaches. While specific mechanisms are not detailed, it suggests a broad approach targeting multiple pathways."
    }
  },
  "NCT05796479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:27.398764Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:27.398776Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4127a3adce40057552d850dd3c85e388",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT01956279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:31.397842Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:31.397853Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "20ade782d3a2ca2477e2ce4897db8f8c",
      "primary_moa": "Neurosteroid modulation of neuroinflammation and neuroprotection"
    }
  },
  "NCT01637779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.5,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:35.397163Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:35.397184Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "96e85ce973b2a248cdc061c4f328d950",
      "primary_moa": "The trial suggests a lack of effect on parent learning about pain management, indicating no significant impact on the DDR, MAPK, PI3K, VEGFR, HER2, IO, or efflux mechanisms."
    }
  },
  "NCT00957879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:39.500902Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:39.500923Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6970616dd2df3b1bcdf19fd66b52ab50",
      "primary_moa": "The study's primary mechanism of action is likely related to the regulation of FGF23 levels by different forms of vitamin D, which may indirectly affect phosphate and vitamin D homeostasis."
    }
  },
  "NCT01867879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 1.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:43.502049Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:43.502087Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f0e6ac39b9d78205767ff95c72d76d27",
      "primary_moa": "Immunotherapy (PD-1, PD-L1 inhibitors)"
    }
  },
  "NCT01596179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:47.276688Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:47.276706Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a84b6d9a2725cf4c568ed1ee204fc81a",
      "primary_moa": "Immunotherapy and Medication Adherence"
    }
  },
  "NCT00604279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:51.226079Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:51.226093Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "180b3ea336302fc394435cb66047ef52",
      "primary_moa": "Neurotransmitter Modulation: The trial focuses on antipsychotic drugs, which primarily work by modulating neurotransmitters like dopamine and serotonin in the brain."
    }
  },
  "NCT06012279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:55.040898Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:55.040912Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "663c0c2a14a020bced76b2d98508d9d6",
      "primary_moa": "Unknown"
    }
  },
  "NCT04406779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:11:58.984682Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:11:58.984690Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8ba67fa46b44cb71d91f23e063261a9e",
      "primary_moa": "The study suggests a potential association between breast cancer and thyroid disorders, indicating a possible dysregulation of the endocrine system. This could involve the MAPK pathway, as thyroid hormones can influence cell growth and differentiation, and mutations in this pathway are associated with cancer."
    }
  },
  "NCT01506479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:02.678127Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:02.678142Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6081655c800a9fe53c36dacb8c23767c",
      "primary_moa": "Exercise-induced neuroprotection and symptom improvement in Parkinson's disease"
    }
  },
  "NCT01406379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:06.648628Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:06.648636Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "596572edf123961a38bdbb9251454dbc",
      "primary_moa": "Prophylactic clip may prevent postpolypectomy bleeding by occluding the large artery in the stalk of the polyp."
    }
  },
  "NCT01889979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:10.550122Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:10.550163Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ec8b26e5248847ccde381e2ac1028126",
      "primary_moa": "Tramadol's mechanism of action involves inhibiting pain signal transmission in the central nervous system, which is relevant to its use in labour analgesia."
    }
  },
  "NCT00293579": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:14.311730Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:14.311749Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a0a9ba5139f1cc60ae8bafc88d54ac83",
      "primary_moa": "Pemetrexed is a folate antagonist that inhibits DNA synthesis and repair, potentially affecting DDR and IO mechanisms."
    }
  },
  "NCT04491279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:18.304249Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:18.304268Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "cdfbb516ccd20fa86146f9925ce56cf1",
      "primary_moa": "Neuropilates may enhance motor recovery and functional independence in chronic stroke patients through targeted muscle activation and neuromuscular re-education."
    }
  },
  "NCT03478579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:22.180387Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:22.180408Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ca30899e27324f75f8b18f3de48e7526",
      "primary_moa": "The trial focuses on the nontechnical skills of emergency physicians in a virtual emergency department, which may indirectly impact patient outcomes. This could potentially influence the quality of care, but the primary mechanism is not directly related to the mechanisms listed."
    }
  },
  "NCT01862679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:26.206617Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:26.206637Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "714ee1062f2fcb98dd0da802a0144947",
      "primary_moa": "Haemodiafiltration (HDF) involves controlling hydrostatic pressure to remove water and toxins, suggesting a focus on fluid balance and toxin removal rather than specific molecular targets."
    }
  },
  "NCT01018979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:29.978310Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:29.978348Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "5a4d0793491ed63414f32f57fe2f279a",
      "primary_moa": "Hematopoietic stem cell mobilization"
    }
  },
  "NCT02738879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:33.866514Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:33.866525Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0044e4f96cd6989eb11302eecd57a5aa",
      "primary_moa": "The primary mechanism of action appears to be the modulation of glucose metabolism and insulin sensitivity, likely through the effects of sitagliptin and insulin glargine."
    }
  },
  "NCT02430779": {
    "moa_vector": {
      "ddr": 0.8,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:37.755689Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:37.755701Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a6b6f12e6cbe64f1ecea35334a542f16",
      "primary_moa": "IRE directly causes permanent pore formation in cell membranes, leading to cell death. This mechanism is primarily classified under DNA Damage Repair (DDR) inhibition, as the process involves significant cellular stress and DNA damage."
    }
  },
  "NCT00515879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:41.758865Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:41.758885Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ef5ac5cec755ad95b2b1572dcd0460b2",
      "primary_moa": "The primary mechanism of action is likely related to the modulation of the nervous system, specifically through the combination of D-cycloserine and cognitive behavioral therapy."
    }
  },
  "NCT04344379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:42.678117Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:42.678134Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "84651f64fefb9c89bf410de02a508afc",
      "primary_moa": "Immunomodulatory and antiviral effects"
    }
  },
  "NCT06423079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:46.771312Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:46.771330Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9016c65fd523442a9f1f958b09cf30d7",
      "primary_moa": "The primary mechanism of action involves the use of novel introflective sutures to provide stable fixation of dislocated bag-IOL complexes, which is particularly beneficial in patients with pseudoexfoliation syndrome."
    }
  },
  "NCT05497479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.5,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:50.758168Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:50.758175Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e529a1593c31dad55e4c0bc9491070b1",
      "primary_moa": "The trial involves the use of AR-15512, a potential drug, to treat Dry Eye Disease, suggesting a focus on drug efficacy and delivery rather than a specific molecular mechanism."
    }
  },
  "NCT00869479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:54.966315Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:54.966332Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8a17741cb8940fd03b2432954b15916d",
      "primary_moa": "The study aims to validate a questionnaire for identifying signs and symptoms of Nephrogenic Systemic Fibrosis (NSF), suggesting a focus on differential diagnosis and symptom recognition rather than a specific mechanism of action."
    }
  },
  "NCT01835379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:12:59.059555Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:12:59.059572Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9a3878090826c3d2a85082f29345d1f9",
      "primary_moa": "Oasis Ultra may enhance wound healing by promoting angiogenesis and reducing inflammation in diabetic foot ulcers."
    }
  },
  "NCT01970579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:02.902859Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:02.902877Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9c73dea52bda3b901920b735da1786cc",
      "primary_moa": "The primary mechanism of action is likely related to the inhibition of restenosis and the promotion of vessel wall stability through the use of paclitaxel, which is known to inhibit cell proliferation and migration."
    }
  },
  "NCT02880579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:06.738809Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:06.738816Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6bd3627b662a918e0669a6dc4dcb94fc",
      "primary_moa": "Neuroprotection and reperfusion therapy for stroke"
    }
  },
  "NCT01824979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:10.560739Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:10.560753Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bc20249eee268934448c1990076181c0",
      "primary_moa": "The study focuses on the Pilairo mask's impact on obstructive sleep apnea, suggesting a primary mechanism related to respiratory function and airway patency."
    }
  },
  "NCT01125579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:14.229876Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:14.229886Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ba79aa340b06825474a8093330c2e083",
      "primary_moa": "Neuromodulation and mood regulation"
    }
  },
  "NCT01561079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:18.512211Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:18.512244Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bcc0e16eff56c0d0d9f3cd09719c4a07",
      "primary_moa": "Neonatal Abstinence Syndrome (NAS) is a condition where newborns exposed to certain substances, such as buprenorphine, exhibit withdrawal symptoms. This trial aims to study the neurobehavioral effects of buprenorphine exposure on the fetus and newborn, suggesting a focus on the effects of the drug on the central nervous system and potential withdrawal symptoms."
    }
  },
  "NCT03039179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:22.205712Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:22.205725Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4950bdc4c30c174345a5e9a0d0166bbf",
      "primary_moa": "Skin protection and healing"
    }
  },
  "NCT05025579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:26.154589Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:26.154602Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "e5b9e86ceaf50bd17bae173b42668c1a",
      "primary_moa": "Aerobic exercise may have a positive impact on depression by improving mood and cognitive function through the release of endorphins and neurotrophic factors."
    }
  },
  "NCT04096079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:30.193811Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:30.193824Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "05c7839c53380fbe5f10210888b9a314",
      "primary_moa": "The study focuses on evaluating the timing of post-ROSC ECG acquisition to reduce false positives and select candidates for emergency coronary angiography, suggesting a focus on cardiac function and angiogenesis."
    }
  },
  "NCT03903679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:34.177754Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:34.177762Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "a4617602e1a099082a2906916393eba2",
      "primary_moa": "Airway management and prevention of airway complications during surgery"
    }
  },
  "NCT00171379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:37.989987Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:37.990008Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "53b188469b4f3ed774c843ae93603093",
      "primary_moa": "Inhibition of T-cell activation and proliferation, likely through the inhibition of inosine monophosphate dehydrogenase (IMPDH) in T-cells, which is a key enzyme in the purine salvage pathway."
    }
  },
  "NCT02584179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:41.760894Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:41.760914Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "8bb6b6fbe36545e5fcfe03648827395d",
      "primary_moa": "The trial focuses on improving diagnosis of significant prostate cancer, suggesting a role in enhancing detection accuracy and reducing false negatives."
    }
  },
  "NCT01425879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 1.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:45.542036Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:45.542061Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "11ed4d610656084d1610706ec320e517",
      "primary_moa": "Akt Inhibitor MK2206 targets the PI3K/AKT pathway, a key driver of cancer cell growth and survival."
    }
  },
  "NCT04071379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:49.646356Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:49.646379Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "881c1845d28dacca9f0388d93b2caeb3",
      "primary_moa": "The trial focuses on the comparison of immunogenicity and safety, suggesting a primary mechanism related to the immune response."
    }
  },
  "NCT00826579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:53.735573Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:53.735580Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "fd3bba0ee455814f1572cf606a24e808",
      "primary_moa": "The study focuses on the sentinel lymph node (SLN) procedure and the detection of micrometastases in colon cancer, suggesting a primary mechanism related to lymphatic drainage and metastatic spread."
    }
  },
  "NCT00453479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:13:58.037796Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:13:58.037813Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c498dc510eb9f7a84e73edfdbe5ec117",
      "primary_moa": "GSK233705B is a muscarinic receptor antagonist, primarily targeting the cholinergic system, which is relevant to COPD treatment."
    }
  },
  "NCT00005179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:01.845534Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:01.845542Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "62a72b1d186b4d6f2e5a30504f9fe73f",
      "primary_moa": "The trial focuses on the transmission of cardiovascular disease risk behaviors from parents to children, suggesting a potential role in the development of cardiovascular diseases and obesity through environmental and behavioral factors."
    }
  },
  "NCT05562479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.5,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:05.788384Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:05.788390Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "69f68141cc2545f199d364a665d53ba0",
      "primary_moa": "The primary mechanism of action appears to be related to the impact of SARS-CoV-2 infection and vaccination on the immune response and ovarian function."
    }
  },
  "NCT03976479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:09.602233Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:09.602271Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "ee97cab1200b7ba9e754821c68ba2114",
      "primary_moa": "The primary mechanism of action appears to be related to the impact of a plant-based diet on body composition, nutritional status, and cardiovascular health, potentially influencing multiple biological pathways."
    }
  },
  "NCT05485779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:13.592102Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:13.592136Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "615e5348acb3e762a1c9b65bf349b235",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT05332379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:17.785360Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:17.785376Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "4061dfe67bf7b2e88fd36d4b70c16f03",
      "primary_moa": "Spinal anesthesia affects regional hemodynamic parameters, potentially influencing nerve fiber function and communication."
    }
  },
  "NCT05721079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.8,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:21.611094Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:21.611111Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "dd63bd39fd60424c3ad63d1e48393faa",
      "primary_moa": "Immunomodulation and Anti-Inflammatory Effects"
    }
  },
  "NCT02660879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:25.398160Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:25.398180Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "d0a287d8bcd8cb960fbabad68f2f653a",
      "primary_moa": "The trial focuses on improving inhaler technique through video education, suggesting a mechanism related to patient education and behavior change."
    }
  },
  "NCT00263679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.3,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:29.318421Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:29.318441Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f35d6f880eb6ea214939af8ce339f7e6",
      "primary_moa": "The primary mechanism of action is likely related to the activation of the immune system to enhance the body's response to the pertussis, diphtheria, and tetanus antigens."
    }
  },
  "NCT04649879": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.4
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:33.189429Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:33.189449Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f7bb42dadb6ae87ea9648602871b53e4",
      "primary_moa": "Immunomodulation and viral clearance"
    }
  },
  "NCT05305079": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.6,
      "her2": 0.0,
      "io": 0.4,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:37.246055Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:37.246064Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f16da5873bf9db19ca88e4961ed9550e",
      "primary_moa": "The study focuses on using advanced imaging techniques (OCT and OCT-A) to investigate the role of anatomical and vascular characteristics of the optic nerve in the development of NA-AION. This suggests a strong emphasis on vascular and anatomical factors, which can be linked to angiogenesis and potentially other pathways."
    }
  },
  "NCT01073579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:41.377038Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:41.377057Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "30eda616f30b35414b271b1595c88c02",
      "primary_moa": "Sabril (vigabatrin) is primarily an anticonvulsant medication used to treat refractory complex partial seizures and infantile spasms. It works by inhibiting GABA-T, an enzyme that breaks down GABA, an inhibitory neurotransmitter. This action increases GABA levels, which helps to reduce seizures."
    }
  },
  "NCT06525779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:45.867435Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:45.867455Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c4f34ea9ba0df9567f32915e3d33f33e",
      "primary_moa": "The trial focuses on the use of different laryngoscopes for double lumen tube insertion, which is a procedure used for anatomical and physiological isolation of the lung. This process involves the introduction of a specialized endotracheal tube, and the use of laryngoscopes is crucial for successful intubation. The primary mechanism of action is likely related to the ease and effectiveness of intubation, which can be influenced by the type of laryngoscope used."
    }
  },
  "NCT01121679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.6,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:49.756030Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:49.756045Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "9d54d5392592449013a96e514134cbfb",
      "primary_moa": "The study suggests a focus on cardiovascular disease in the elderly, potentially involving the PI3K/AKT pathway, as it is a common pathway affected in aging and cardiovascular disorders."
    }
  },
  "NCT02233179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:53.732211Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:53.732230Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "71979744fd4fea2af05f81ee6ec0d3d3",
      "primary_moa": "The study suggests a potential association between physical activity and wound healing in diabetic patients, which may involve multiple mechanisms."
    }
  },
  "NCT04007679": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:14:57.947377Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:14:57.947393Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b1f63633cd29cf9d1b4289e27fb7d28d",
      "primary_moa": "Pain neuroscience education (PNE) is a non-pharmacological intervention that aims to improve pain understanding and management. It focuses on educating individuals about the neurobiological basis of pain, challenging maladaptive beliefs, and promoting adaptive coping strategies."
    }
  },
  "NCT05550779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.6,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:01.744921Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:01.744937Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "6014d75df93470cc8e53a0d937d7a648",
      "primary_moa": "Cognitive Enhancement"
    }
  },
  "NCT05821179": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:05.921237Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:05.921268Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "f32d679243e16b3085a6ca9828fb675a",
      "primary_moa": "The study suggests a potential role of LINC00657 in the context of oral cancer, possibly related to its association with miR-106a and its diagnostic potential. However, the specific mechanism of action is not clearly defined in the provided information."
    }
  },
  "NCT01146379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:09.838036Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:09.838048Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "933f89ccea4d403ae87dd775b15e266e",
      "primary_moa": "Intensive task-specific upper extremity rehabilitation likely enhances motor recovery by promoting neuroplasticity and motor learning."
    }
  },
  "NCT02885779": {
    "moa_vector": {
      "ddr": 0.2,
      "mapk": 0.1,
      "pi3k": 0.1,
      "vegf": 0.1,
      "her2": 0.1,
      "io": 0.2,
      "efflux": 0.0
    },
    "confidence": 0.5,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:14.016449Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:14.016460Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "70c22b30581f641d1651ddae76ff1dfc",
      "primary_moa": "This trial focuses on comparing surgical techniques in gynecological adnexa surgeries, specifically the use of mini-trocar and monotrocar approaches. While it does not directly target molecular pathways, it suggests a focus on improving surgical outcomes and reducing morbidity, which could indirectly impact cellular processes and potentially involve mechanisms such as DNA damage repair and immune modulation."
    }
  },
  "NCT03644979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:18.041440Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:18.041453Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "c71d0b7ceb32d2c1daa365f7c1dc24ad",
      "primary_moa": "Psychological stress from skydiving may affect intestinal permeability through various pathways, including stress-induced inflammation and altered gut microbiota."
    }
  },
  "NCT04509479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:22.122983Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:22.122998Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "0481c00fe0e3262197bc75c1d6efb37d",
      "primary_moa": "Valve replacement therapy primarily addresses valvular heart disease, stenosis, and insufficiency, focusing on mechanical support and relief of symptoms."
    }
  },
  "NCT01408979": {
    "moa_vector": {
      "ddr": 0.4,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.6,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:25.965689Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:25.965696Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "93a89ab3c7f7c2e6dbf07550774893ac",
      "primary_moa": "Magnesium sulfate may act by inhibiting DNA damage repair and enhancing the immune response."
    }
  },
  "NCT04660279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:29.952706Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:29.952725Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "bed94e47e6255be32c6c38ff41ac106a",
      "primary_moa": "Dynamic FDG PET/CT trial focuses on optimizing glucose metabolism quantification, which is a metabolic process. This involves imaging and analyzing blood and tissue activity concentrations, suggesting a metabolic pathway involvement."
    }
  },
  "NCT00987779": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:33.879570Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:33.879589Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "57e04d27cf9b3135c0d42e0d14fe5e70",
      "primary_moa": "Bioequivalence study of Gabapentin between tablet and liquid formulation, with a focus on the liquid formulation's food effect."
    }
  },
  "NCT01632579": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.8,
      "pi3k": 0.7,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.5,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:37.848848Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:37.848855Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "79544c2150d26072ce31f084981c874e",
      "primary_moa": "LY3023703 is a COX-2 inhibitor, which primarily affects the MAPK and PI3K/AKT pathways."
    }
  },
  "NCT04333979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:41.692024Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:41.692056Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "1b413510fc4d0f6afde2b6d3db4547c9",
      "primary_moa": "The trial suggests a focus on patient comfort and recovery post-surgery, which may involve reducing post-operative pain and promoting faster healing. This could potentially involve mechanisms related to inflammation and tissue repair."
    }
  },
  "NCT03824379": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:45.867631Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:45.867645Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "50f65cca719f9a99aeeccc60354ae1dc",
      "primary_moa": "Magnesium supplementation may improve cardiovascular complications, insulin resistance, lipid profile, and kidney function in diabetic nephropathy patients."
    }
  },
  "NCT04691479": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.8,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:49.797004Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:49.797011Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "45c24af2bad5b5e0d9d31484c4ed7027",
      "primary_moa": "Motivational Interviewing and Adherence Follow-Up"
    }
  },
  "NCT03332979": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.7,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:53.647665Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:53.647671Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "b7b39c5fa050a1d9c893e1c9332fa804",
      "primary_moa": "The study examines the relationship between carers' feelings of grief and their preparation for the death of a person with dementia, suggesting a focus on psychological and emotional support rather than a direct biological mechanism."
    }
  },
  "NCT02203279": {
    "moa_vector": {
      "ddr": 0.0,
      "mapk": 0.0,
      "pi3k": 0.0,
      "vegf": 0.0,
      "her2": 0.0,
      "io": 0.0,
      "efflux": 0.0
    },
    "confidence": 0.0,
    "source": "cohere_batch_tagging",
    "tagged_at": "2026-01-09T00:15:57.530628Z",
    "reviewed_by": "TrialTaggingAgent",
    "provenance": {
      "model": "command-r7b-12-2024",
      "provider": "cohere",
      "version": "v1",
      "parsed_at": "2026-01-09T00:15:57.530634Z",
      "reviewed_by": "TrialTaggingAgent",
      "source_checksum": "82478e7e17f2c875a47e6324d942a1e7",
      "primary_moa": "No clear mechanism of action identified"
    }
  },
  "NCT03579316": {
    "moa_vector": {
      "ddr": "Yes",
      "mapk": "Yes",
      "pi3k": "Yes",
      "vegf": "No",
      "her2": "No",
      "io": "No",
      "efflux": "No"
    },
    "confidence": "High",
    "primary_moa": "DDR and MAPK",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.173910",
      "source_checksum": "4acb5458f59c927734dd2f02da3b9f0c",
      "source": "llm_batch_tagging"
    }
  },
  "NCT02264678": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "Yes",
      "pi3k": "Yes",
      "vegf": "No",
      "her2": "No",
      "io": "No",
      "efflux": "No"
    },
    "confidence": "Medium",
    "primary_moa": "PI3K",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.173987",
      "source_checksum": "2a3f5ae31f47680e8c2d47a3814a327a",
      "source": "llm_batch_tagging"
    }
  },
  "NCT04585750": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "No",
      "pi3k": "No",
      "vegf": "No",
      "her2": "No",
      "io": "No",
      "efflux": "No"
    },
    "confidence": "Low",
    "primary_moa": "Not Applicable",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.174008",
      "source_checksum": "ad08c24fdcfc08f3fe1d05915487b88f",
      "source": "llm_batch_tagging"
    }
  },
  "NCT04034927": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "No",
      "pi3k": "No",
      "vegf": "No",
      "her2": "No",
      "io": "Yes",
      "efflux": "No"
    },
    "confidence": "High",
    "primary_moa": "IO",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.174030",
      "source_checksum": "85f0e065bbe5108a34924a5f8293aa93",
      "source": "llm_batch_tagging"
    }
  },
  "NCT06107868": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "No",
      "pi3k": "No",
      "vegf": "No",
      "her2": "No",
      "io": "No",
      "efflux": "No"
    },
    "confidence": "Low",
    "primary_moa": "Not Applicable",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.174038",
      "source_checksum": "0b71d95111bd935e70d9928f2f5a6bb9",
      "source": "llm_batch_tagging"
    }
  },
  "NCT02571725": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "No",
      "pi3k": "No",
      "vegf": "No",
      "her2": "No",
      "io": "Yes",
      "efflux": "No"
    },
    "confidence": "Medium",
    "primary_moa": "IO",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.174049",
      "source_checksum": "86a57eb9fa173a59d5ddde3ff64e6443",
      "source": "llm_batch_tagging"
    }
  },
  "NCT05877599": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "No",
      "pi3k": "No",
      "vegf": "No",
      "her2": "No",
      "io": "No",
      "efflux": "No"
    },
    "confidence": "Low",
    "primary_moa": "Not Applicable",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.174059",
      "source_checksum": "c873c0c7531e787c59fc68b72f1c1b4f",
      "source": "llm_batch_tagging"
    }
  },
  "NCT05990192": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "No",
      "pi3k": "No",
      "vegf": "No",
      "her2": "No",
      "io": "No",
      "efflux": "No"
    },
    "confidence": "Low",
    "primary_moa": "Not Applicable",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.174071",
      "source_checksum": "28a3dd61ae848c4fcac8b057f46e1a53",
      "source": "llm_batch_tagging"
    }
  },
  "NCT06827353": {
    "moa_vector": {
      "ddr": "No",
      "mapk": "No",
      "pi3k": "No",
      "vegf": "No",
      "her2": "No",
      "io": "Yes",
      "efflux": "No"
    },
    "confidence": "Medium",
    "primary_moa": "IO",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:18.174077",
      "source_checksum": "5cecff4cd749d76ce9c2c1caad1f4268",
      "source": "llm_batch_tagging"
    }
  },
  "NCT06433219": {
    "moa_vector": {
      "ddr": "Tuvusertib",
      "mapk": "Niraparib",
      "pi3k": "Lartesertib",
      "vegf": "",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "High",
    "primary_moa": "DDR",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.596939",
      "source_checksum": "ff62d2ce374f9f1884963bf317baa93c",
      "source": "llm_batch_tagging"
    }
  },
  "NCT06545942": {
    "moa_vector": {
      "ddr": "MOMA-313",
      "mapk": "",
      "pi3k": "",
      "vegf": "",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "Medium",
    "primary_moa": "DDR",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.596973",
      "source_checksum": "28b77862272b3fdd3e7633b0a82d34ec",
      "source": "llm_batch_tagging"
    }
  },
  "NCT06856499": {
    "moa_vector": {
      "ddr": "Cirtuvivint",
      "mapk": "",
      "pi3k": "Olaparib",
      "vegf": "",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "High",
    "primary_moa": "DDR",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.596989",
      "source_checksum": "e396000d2d254a42e17c5d20b967100d",
      "source": "llm_batch_tagging"
    }
  },
  "NCT03740165": {
    "moa_vector": {
      "ddr": "",
      "mapk": "Pembrolizumab",
      "pi3k": "",
      "vegf": "Bevacizumab",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "Medium",
    "primary_moa": "MAPK",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.597001",
      "source_checksum": "0e24d33593992c00eb40e4c18f251e1e",
      "source": "llm_batch_tagging"
    }
  },
  "NCT04616534": {
    "moa_vector": {
      "ddr": "Elimusertib",
      "mapk": "",
      "pi3k": "",
      "vegf": "",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "High",
    "primary_moa": "DDR",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.597024",
      "source_checksum": "39ab684b5ee5fb5a444dade8381cf364",
      "source": "llm_batch_tagging"
    }
  },
  "NCT03113487": {
    "moa_vector": {
      "ddr": "Modified Vaccinia Virus Ankara Vaccine Expressing p53",
      "mapk": "Pembrolizumab",
      "pi3k": "",
      "vegf": "",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "Medium",
    "primary_moa": "DDR",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.597035",
      "source_checksum": "fcf3811c7f761970dde85bf6b6061d2e",
      "source": "llm_batch_tagging"
    }
  },
  "NCT02298959": {
    "moa_vector": {
      "ddr": "",
      "mapk": "Pembrolizumab",
      "pi3k": "",
      "vegf": "Ziv-aflibercept",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "Medium",
    "primary_moa": "MAPK",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.597041",
      "source_checksum": "54a3f10f6ed0c1ea01d5ab1eebf993e5",
      "source": "llm_batch_tagging"
    }
  },
  "NCT03522246": {
    "moa_vector": {
      "ddr": "Rucaparib",
      "mapk": "",
      "pi3k": "Nivolumab",
      "vegf": "",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "High",
    "primary_moa": "DDR",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.597048",
      "source_checksum": "d98cbf05d9f12528f7373e6bdfcc6965",
      "source": "llm_batch_tagging"
    }
  },
  "NCT04044859": {
    "moa_vector": {
      "ddr": "ADP-A2M4CD8",
      "mapk": "",
      "pi3k": "Nivolumab",
      "vegf": "Pembrolizumab",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "Medium",
    "primary_moa": "DDR",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.597055",
      "source_checksum": "2e5c7b05a05e9cc46b251a14f313eda0",
      "source": "llm_batch_tagging"
    }
  },
  "NCT03734692": {
    "moa_vector": {
      "ddr": "",
      "mapk": "Rintatolimod",
      "pi3k": "Pembrolizumab",
      "vegf": "Cisplatin",
      "her2": "",
      "io": "",
      "efflux": ""
    },
    "confidence": "Medium",
    "primary_moa": "MAPK",
    "provenance": {
      "provider": "cohere",
      "model": "command-r7b-12-2024",
      "parsed_at": "2026-01-11T15:37:27.597062",
      "source_checksum": "d6cd2e33634d982895087c91ae569ad0",
      "source": "llm_batch_tagging"
    }
  }
}